≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Glaucoma suspect

DOID EFO Endpoint Browser PheWeb

H7_GLAUCSUSP

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H40.0
  • Hospital discharge: ICD-9 — 3650
  • Hospital discharge: ICD-8 — 37597
  • Cause of death: ICD-10 — H40.0
  • Cause of death: ICD-9 — 3650
  • Cause of death: ICD-8 — 37597

2 out of 7 registries used, show all original rules.

15900

4. Check minimum number of events

None

15900

5. Include endpoints

None

15900

6. Filter based on genotype QC (FinnGen only)

15900

Control definitions (FinnGen only)

Control exclude
H7_GLAUCOMA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H40
Name in latin
Suspicio glaucomatis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 116607 73712 42352
Only index persons 106382 67668 38714
Unadjusted period prevalence (%)
Whole population 1.77 2.11 1.18
Only index persons 2.12 2.49 1.48
Median age at first event (years)
Whole population 65.41 65.92 64.57
Only index persons 65.11 65.57 64.31

-FinnGen-

Key figures

All Female Male
Number of individuals 15900 9747 6153
Unadjusted period prevalence (%) 3.09 3.32 2.71
Median age at first event (years) 64.71 63.78 66.19

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
14068
Matched controls
140675
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
CHC05
NOMESCO Finland
Iridotomy
84.5
323.0
1112
143
S01EC54
ATC
brinzolamide, combinations; ophthalmic
73.5
323.0
491
69
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
7.0
323.0
3200
5696
S01EE05
ATC
tafluprost; ophthalmic
30.7
323.0
1694
623
S01EE04
ATC
travoprost; ophthalmic
28.6
323.0
921
344
S01ED51
ATC
timolol, combinations; ophthalmic
30.4
323.0
3886
1745
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.6
323.0
1611
3818
XCH05
NOMESCO Finland
Eye pressure longterm registration
279.1
323.0
689
26
Z96.1
ICD-10 Finland
Presence of intraocular lens
3.8
323.0
3333
10614
H25.1
ICD-10 Finland
Senile nuclear cataract
2.2
323.0
4857
26819
XCK00
NOMESCO Finland
Perimetry
24.3
323.0
4296
2495
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
102.2
323.0
727
75
XCK10
NOMESCO Finland
Photography of fundus of eye
4.6
323.0
2834
7292
S01EX03
ATC
NA
35.2
323.0
855
258
XCH00
NOMESCO Finland
Eye pressure measurement
11.0
323.0
1735
1770
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
37.6
323.0
1354
397
H40.11
ICD-10 Finland
Low pressure glaucoma
259.5
323.0
1101
46
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
2176.4
323.0
442
*
S01EC03
ATC
dorzolamide; ophthalmic
40.9
323.0
554
141
S01ED01
ATC
timolol; ophthalmic
20.8
323.0
1548
830
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
53.5
323.0
1555
326
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
1441.0
323.0
2193
18
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
393.0
323.0
1330
37
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.3
323.0
5784
32893
H40.9
ICD-10 Finland
Glaucoma, unspecified
98.6
323.0
756
81
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
323.0
6820
44168
XCW99
NOMESCO Finland
Other investigative procedure of eye
6.2
323.0
3713
7731
S01EC04
ATC
brinzolamide; ophthalmic
43.1
323.0
1807
479
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
84.3
323.0
1174
152
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
31.3
323.0
1912
702
CHD00
NOMESCO Finland
Laser trabeculoplasty
702.8
323.0
798
12
CS494
NOMESCO Finland
Other visual field testing
21.0
323.0
1018
521
CS2P4
NOMESCO Finland
Optic nerve head imaging
150.3
323.0
437
30
H40.0
ICD-10 Finland
Glaucoma suspect
7073.1
323.0
13532
381
H40.22
ICD-10 Finland
Chronic glaucoma with closed ventricular angle
+∞
323.0
316
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.6
323.0
4294
12301
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
175.4
323.0
1160
72
3650A
ICD-9 Finland
Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]
+∞
323.0
389
*
114
Kela drug reimbursment
Glaucoma
42.4
323.0
5106
1864
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
304.2
323.0
2901
120
S01EE01
ATC
latanoprost; ophthalmic
32.8
323.0
3345
1324
S01EC01
ATC
acetazolamide; systemic
14.4
323.0
718
522
S01EE03
ATC
bimatoprost; ophthalmic
38.8
323.0
1004
278
37597
ICD-8 Finland
Glaucoma, Suspicio glaucomatis
+∞
315.7
302
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.0
313.4
5788
36109
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
+∞
300.0
287
*
S01ED02
ATC
betaxolol; ophthalmic
36.7
299.3
389
109
ZXA10
NOMESCO Finland
Bilateral
2.2
270.3
3316
17139
H40
ICD-10 Finland
Glaucoma
24.9
259.3
372
153
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
+∞
219.3
210
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.2
194.2
795
1985
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.5
187.8
1600
6760
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
1941.1
186.7
181
*
WX140
NOMESCO Finland
Parabulbar anesthesy
3.6
179.0
859
2462
H20.1
ICD-10 Finland
Chronic iridocyclitis
11.5
178.7
345
308
H40.20
ICD-10 Finland
Acute glaucoma with closed ventricular angle
1702.2
166.9
162
*
S01EB01
ATC
pilocarpine; ophthalmic
31.0
163.1
220
72
S01EA03
ATC
apraclonidine; ophthalmic
13.2
163.0
294
227
CHD35
NOMESCO Finland
Laser goniopuncture
1628.2
160.6
156
*
H26.4
ICD-10 Finland
After-cataract
2.3
158.7
1686
7935
SPAT1009
SPAT
Measurement of intraocular pressure
6.7
147.5
393
601
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
146.1
140
*
F93
ICPC
Glaucoma
47.7
145.8
179
38
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.1
141.5
1912
9969
3651A
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]
+∞
135.6
130
*
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
6.0
133.2
383
648
H40.8
ICD-10 Finland
Other glaucoma
128.5
130.3
140
11
H40.19
ICD-10 Finland
Other primary glaucoma with open ventricular angle
1229.4
125.2
122
*
CHD99
NOMESCO Finland
Other filtering operation
1127.7
114.8
112
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.7
111.3
846
3310
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
3.9
104.5
454
1189
S01EA02
ATC
dipivefrine; ophthalmic
123.2
102.1
110
9
H52.1
ICD-10 Finland
Myopia
4.0
102.0
434
1116
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
965.2
98.1
96
*
H40.12
ICD-10 Finland
Pigmentary glaucoma
476.0
95.5
95
*
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
95.2
1397
7448
CKC12
NOMESCO Finland
Photocoagulation of retina
2.8
94.2
654
2417
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.4
92.8
482
1461
H34.8
ICD-10 Finland
Other retinal vascular occlusions
3.8
90.9
408
1099
CK2P4
NOMESCO Finland
Optic nerve head light layer imaging (OCT)
59.3
90.0
106
18
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.3
86.5
467
1457
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
7.6
83.5
201
266
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
80.7
1216
6528
H40.3
ICD-10 Finland
Glaucoma secondary to eye trauma
+∞
80.3
77
*
CKD40
NOMESCO Finland
Endophotocoagulation of retina
4.6
74.6
268
586
CD2S4
NOMESCO Finland
Photography of eye
9.8
74.6
154
158
SPAT1301
SPAT
No procedures
1.4
72.9
4227
32415
XCW10
NOMESCO Finland
Assessment of vision
8.6
72.7
162
190
H25.0
ICD-10 Finland
Senile incipient cataract
2.0
67.3
907
4652
37510
ICD-8 Finland
Glaucoma, Chronicum simplex
+∞
66.7
64
*
SPAT1312
SPAT
General health counselling
1.4
63.6
3929
30311
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
62.7
5444
44510
H40.1
ICD-10 Finland
Primary open-angle glaucoma
33.9
61.9
81
24
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.4
61.1
316
955
SPAT1263
SPAT
Sampling
1.4
61.1
5356
43802
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.3
61.0
317
962
SPAT1262
SPAT
Handing over of treatment supplies
1.5
60.8
2375
16687
CFW99
NOMESCO Finland
Other operation on conjunctiva
58.6
59.5
70
12
H3603, E103
ICD-10 Finland
NA
5.9
58.6
170
293
F43
ICPC
Eye, Other diagnostic procedure
3.7
58.5
268
736
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
2.4
58.2
517
2193
CA1ME
NOMESCO Finland
Ultrasound oculometry
5.7
56.0
165
290
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.5
54.6
445
1803
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.9
54.5
355
1260
H57.1
ICD-10 Finland
Ocular pain
2.7
53.9
398
1526
T89
ICPC
Diabetes insulin dependent
2.5
53.0
430
1738
H26.2
ICD-10 Finland
Complicated cataract
4.0
51.6
215
545
SPAT1310
SPAT
Counselling related to known health issue
1.4
51.3
3941
31299
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
6.6
51.3
135
205
CKD20
NOMESCO Finland
Removal of vitreous body substitute
7.8
50.2
118
152
H16.0
ICD-10 Finland
Corneal ulcer
2.2
49.3
530
2465
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
3.1
48.7
286
947
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.3
48.6
460
2014
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
2.3
48.6
452
1963
ZXA05
NOMESCO Finland
Left side
1.4
48.5
3316
25788
A10AA01
ATC
NA
2.8
47.7
320
1159
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.5
47.3
376
1504
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
47.0
891
5142
A10AA02
ATC
NA
2.4
47.0
421
1794
3651B
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]
+∞
46.9
45
*
TCG20
NOMESCO Finland
Laser suture lysis in cornea or sclera
+∞
46.9
45
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.8
45.9
920
5405
SPAT1153
SPAT
Removal of sutures
1.3
44.6
4092
33240
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
7.9
43.3
101
129
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
5.3
42.8
135
259
H40.21
ICD-10 Finland
Intermittent glaucoma with closed ventricular angle
418.9
42.2
42
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
42.1
4766
39805
A98
ICPC
Health maint/preventive medicine
1.5
42.1
12730
121723
H3600, E103
ICD-10 Finland
NA
4.5
41.6
153
346
CKD15
NOMESCO Finland
Injection of vitreous substitute
7.3
40.1
98
135
H3601, E103
ICD-10 Finland
NA
4.8
40.0
136
284
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
39.9
2956
23164
WX720
NOMESCO Finland
Own respiration
2.1
39.8
485
2381
H04AA01
ATC
glucagon; nasal, parenteral
3.0
39.3
232
772
A10AE05
ATC
insulin detemir; parenteral
1.9
39.3
643
3532
S01BC03
ATC
diclofenac; ophthalmic
2.5
39.1
326
1339
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
39.1
3739
30429
CHC03
NOMESCO Finland
Laser iridoplasty
137.0
38.7
41
*
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
378.4
38.0
38
*
CKC10
NOMESCO Finland
Local photocoagulation of retina
2.7
37.5
266
998
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.8
37.4
731
4255
SPAT1325
SPAT
Vaccination
1.3
36.6
4417
37022
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
6.2
36.5
100
162
A10AE04
ATC
insulin glargine; parenteral
1.6
36.2
1073
7010
ZXA00
NOMESCO Finland
Right side
1.3
36.1
3464
28134
SPAT1260
SPAT
Consultation of another employee
1.4
35.3
2145
16235
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.6
35.2
1100
7279
H27.8
ICD-10 Finland
Other specified disorders of lens
6.9
35.1
89
130
F38
ICPC
Eye, Other laboratory test NEC
7.1
35.1
87
123
H52.2
ICD-10 Finland
Astigmatism
3.3
35.1
180
545
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.9
34.9
216
746
H25.8
ICD-10 Finland
Other senile cataract
1.5
34.9
1440
10134
H27.1
ICD-10 Finland
Dislocation of lens
6.7
34.4
89
134
H26.02
ICD-10 Finland
Presenil cataract
2.3
34.0
339
1525
H36.00
ICD-10 Finland
Diabetic background retinopathy
3.1
33.9
195
641
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
33.5
2453
19114
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
2.9
33.5
211
737
H52.0
ICD-10 Finland
Hypermetropia
2.8
33.0
215
767
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
2.0
32.9
444
2272
H36.01
ICD-10 Finland
Diabetic maculopathy
3.3
32.8
168
508
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
3.9
32.7
140
366
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
2.7
32.6
229
855
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
3.3
31.9
168
520
WX142
NOMESCO Finland
Sub-tenon anesthesy
5.7
31.6
92
162
XCD20
NOMESCO Finland
Photoangiography of eye
2.6
31.3
239
937
F29
ICPC
Eye symptom/complaint other
1.6
31.1
910
5920
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
12.5
30.6
55
44
H53.4
ICD-10 Finland
Visual field defects
2.4
30.4
257
1066
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
30.2
702
4301
CJ2M4
NOMESCO Finland
Scans and measurement printouts for intraocular lens power calculation
3.1
30.0
167
538
CHF15
NOMESCO Finland
Cryotherapy of ciliary body
155.3
29.6
31
*
H27.0
ICD-10 Finland
Aphakia
8.1
29.6
67
83
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
5.8
29.5
85
148
WX704
NOMESCO Finland
Intubation
1.6
29.4
802
5125
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
29.3
3221
26507
ZXC20
NOMESCO Finland
Use of chemical agents
2.4
29.3
257
1087
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
2.8
29.3
192
689
SPAT1097
SPAT
Recording of ECG
1.4
29.2
1860
14143
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
4.5
29.0
104
231
T90
ICPC
Diabetes non-insulin dependent
1.3
28.9
2767
22351
UJF32
NOMESCO Finland
Coloscopy
1.3
28.4
3167
26095
CKC15
NOMESCO Finland
Panretinal photocoagulation
3.7
28.3
126
342
S18
ICPC
Laceration/cut
1.2
28.2
5124
44674
H40.29
ICD-10 Finland
Other [primary] glaucoma with closed ventricular angle
+∞
28.1
27
*
H21.0
ICD-10 Finland
Hyphaema
6.6
27.7
72
110
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
1.7
27.5
537
3127
A10AE06
ATC
insulin degludec; parenteral
2.2
27.4
293
1364
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.1
27.3
307
1459
CG2T4
NOMESCO Finland
Topography assessment of cornea
3.8
27.1
118
315
3650B
ICD-9 Finland
Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AHDASKULMA)]
+∞
27.1
26
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
27.0
3538
29702
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
4.0
26.7
109
275
H3603, E113
ICD-10 Finland
NA
3.5
26.7
127
365
3708
FHL
Trabeculectomy or equivalent
140.2
26.6
28
*
-44
ICPC
Preventive immunization/medic
1.5
25.6
1001
6948
CHC00
NOMESCO Finland
Iridotomy
93.5
25.6
28
*
F99
ICPC
Eye/adnexa disease other
4.3
25.4
95
221
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
2.2
25.1
269
1252
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
25.0
7722
70677
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
24.8
2400
19369
S01BC05
ATC
ketorolac; ophthalmic
1.7
24.6
488
2856
C08CA01
ATC
amlodipine; oral
1.2
24.6
4545
39539
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.8
24.1
429
2426
J01DB01
ATC
cefalexin; oral
1.2
24.0
10153
95618
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
24.0
2515
20493
R51.80
ICD-10 Finland
Headache
1.4
24.0
1407
10535
S01EX
ATC
Other antiglaucoma preparations
+∞
24.0
23
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
23.8
2074
16492
C09CA01
ATC
losartan; oral
1.3
23.8
2924
24296
E0000UV
ATC
NA
1.2
23.6
4396
38231
S01FA04
ATC
cyclopentolate; ophthalmic
2.9
22.9
139
477
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
22.7
7911
72902
CHD10
NOMESCO Finland
Trabeculectomy
230.3
22.6
23
*
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
22.6
6989
63693
N02BE01
ATC
paracetamol; systemic, rectal
1.2
22.4
11228
107100
H3601, E113
ICD-10 Finland
NA
2.4
22.4
193
813
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.7
22.3
98
265
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
22.2
6143
55379
Z3231
NOMESCO Finland
Registered nurse
1.2
22.2
3102
26124
H20.8
ICD-10 Finland
Other iridocyclitis
5.4
22.2
67
125
37520
ICD-8 Finland
Glaucoma, Secondary
+∞
21.9
21
*
R44
ICPC
Respiratory, Preventive immunization/medic
2.2
21.8
225
1031
XF400
NOMESCO Finland
ECG with 12 standard connections
0.7
21.8
1171
15343
CKD60
NOMESCO Finland
Anterior vitrectomy
3.1
21.3
120
393
H35.36
ICD-10 Finland
Macular cyst
3.6
21.2
98
277
WX110
NOMESCO Finland
Local anesthesy
1.2
21.2
7906
73065
N03AX12
ATC
gabapentin; oral
1.3
21.0
1718
13518
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
1.9
21.0
311
1654
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.9
20.9
310
1649
AA1AD
NOMESCO Finland
CT of head and brain
1.2
20.9
2843
23849
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.5
20.9
167
676
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
20.8
3390
28986
S01EX05
ATC
netarsudil; ophthalmic
+∞
20.8
20
*
WX400
NOMESCO Finland
Inhalation anesthesy
1.7
20.8
417
2451
H01.0
ICD-10 Finland
Blepharitis
1.6
20.8
511
3179
WX002
NOMESCO Finland
Sedation and analgesia
1.3
20.6
2285
18707
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
20.5
3927
34126
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.6
20.3
551
3521
A02BC03
ATC
lansoprazole; oral
1.2
20.0
3499
30117
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
19.4
5715
51577
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
19.4
1906
15364
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
19.3
485
3036
R42
ICD-10 Finland
Dizziness and giddiness
1.2
19.2
2593
21703
R01AD09
ATC
mometasone; nasal
1.2
19.1
4782
42539
D82
ICPC
Teeth/gum disease
1.2
18.8
3366
29006
-1
NOMESCO Finland
NA
1.2
18.7
3277
28181
H02.4
ICD-10 Finland
Ptosis of eyelid
1.8
18.7
313
1739
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
1.8
18.6
307
1698
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
18.5
2620
22029
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.1
18.5
211
1013
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
18.4
3413
29509
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
9.5
18.3
37
39
H13
ICPC
Plugged feeling ear
1.3
18.1
2031
16626
CFB00
NOMESCO Finland
Suture of conjunctiva
11.0
18.1
34
31
C10AA07
ATC
rosuvastatin; oral
1.2
17.6
2836
24150
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.2
17.6
2707
22944
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.6
17.5
423
2627
CJF45
NOMESCO Finland
Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy
7.1
17.4
42
59
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
3.4
17.4
84
248
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.5
17.2
521
3422
H30.2
ICD-10 Finland
Posterior cyclitis
5.6
17.1
49
87
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
6.9
17.1
42
61
L17
ICPC
Foot/toe symptom/complaint
1.2
17.0
2814
24031
H44.5
ICD-10 Finland
Degenerated conditions of globe
17.4
16.9
26
15
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
2.8
16.7
109
396
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
3.4
16.5
81
242
R4180
NOMESCO Finland
Podiatric therapy
2.5
16.5
124
489
CKC60
NOMESCO Finland
Local buckling of sclera using implant
3.3
16.5
83
253
TCG10
NOMESCO Finland
Removal of sutures from cornea
3.7
16.4
71
192
H18.1
ICD-10 Finland
Bullous keratopathy
5.9
16.4
45
76
H3600, E113
ICD-10 Finland
NA
2.2
16.4
159
714
CJF30
NOMESCO Finland
Reduction of dislocation of artificial lens
5.8
16.4
46
80
C10AA05
ATC
atorvastatin; oral
1.2
16.2
4726
42424
H33.3
ICD-10 Finland
Retinal breaks without detachment
1.7
16.2
355
2148
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.2
16.2
5303
48047
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
16.1
3141
27222
CHB99
NOMESCO Finland
Other operation on anterior chamber and anterior chamber angle
30.0
16.1
21
7
D07AC01
ATC
betamethasone; topical
1.2
16.0
3803
33544
CKC20
NOMESCO Finland
Cryopexy of undetached retina
5.5
15.8
46
84
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
15.7
4359
38943
N06AX11
ATC
mirtazapine; oral
1.2
15.5
3471
30444
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.4
15.5
849
6276
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
15.5
5082
46004
R09
ICPC
Sinus symptom/complaint
1.4
15.4
657
4637
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
15.4
4374
39142
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
15.3
5997
55000
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
3.1
15.2
82
264
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
15.2
2816
24273
M79.6
ICD-10 Finland
Pain in limb
1.2
15.1
4025
35808
F27
ICPC
Fear of eye disease
2.5
15.1
114
451
ZX198
NOMESCO Finland
Other local administration
2.4
15.1
127
532
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
3.2
15.1
79
249
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.3
15.0
141
624
H16.9
ICD-10 Finland
Keratitis, unspecified
2.2
15.0
152
699
F01
ICPC
Eye pain
1.8
14.9
256
1438
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
14.9
1399
11192
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
5.2
14.7
45
87
CH2X4
NOMESCO Finland
Optical coherence tomography (OCT) of iris and iridocorneal angle
8.6
14.7
31
36
H31.4
ICD-10 Finland
Choroidal detachment
21.0
14.6
21
10
WX144
NOMESCO Finland
Subconjunctival anesthesy
2.3
14.6
136
601
R01AD12
ATC
fluticasone furoate; nasal
1.2
14.6
2739
23624
A02BC05
ATC
esomeprazole; systemic
1.2
14.4
4707
42513
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.3
14.4
997
7645
UDC00
NOMESCO Finland
Ear microscopy
1.4
14.4
740
5413
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.1
14.3
76
243
F05
ICPC
Visual disturbance other
1.7
14.3
279
1633
XQ845
NOMESCO Finland
Dermatoscopy
2.1
14.2
152
716
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.2
14.2
2426
20738
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
14.2
3332
29311
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
2.1
14.1
158
759
G47.3
ICD-10 Finland
Sleep apnoea
1.2
14.0
2064
17377
G04CA02
ATC
tamsulosin; oral
1.2
13.9
2221
18852
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.2
13.9
2416
20676
N03AX16
ATC
pregabalin; oral
1.2
13.9
2607
22473
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.4
13.8
713
5213
J01FA10
ATC
azithromycin; systemic
1.1
13.8
6203
57302
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
1.9
13.7
190
993
C10AA01
ATC
simvastatin; oral
1.1
13.7
5594
51320
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
3.7
13.7
59
161
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
13.6
2844
24747
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
13.6
1432
11617
VALMI
NOMESCO Finland
NA
1.2
13.5
2307
19700
S01AD03
ATC
aciclovir; ophthalmic
1.6
13.5
371
2382
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.4
13.5
673
4892
R06AX27
ATC
desloratadine; oral
1.2
13.5
2470
21241
K02.1
ICD-10 Finland
Caries of dentine
1.1
13.4
5862
53999
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
13.2
4684
42499
M03BX02
ATC
tizanidine; oral
1.1
13.2
6916
64490
M01AC06
ATC
meloxicam; systemic, rectal
1.2
13.1
4243
38229
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.2
13.1
1809
15121
ZXC50
NOMESCO Finland
Cryotherapy
1.6
13.1
330
2077
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
13.1
4242
38227
CK2M4
NOMESCO Finland
Macular light layer imaging (OCT)
4.0
13.0
51
128
R01AD08
ATC
fluticasone; nasal
1.2
13.0
2852
24911
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.4
12.9
532
3737
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.4
12.9
529
3710
J02AC01
ATC
fluconazole; systemic
1.2
12.9
4257
38409
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
12.8
2019
17097
SXA05
NOMESCO Finland
NA
2.4
12.8
103
423
R4110
NOMESCO Finland
Physiotherapy
0.8
12.8
2263
26131
SPAT1016
SPAT
Examination of vision
1.5
12.8
430
2896
H26.3
ICD-10 Finland
Drug-induced cataract
2.9
12.7
75
258
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
12.7
3016
26510
S05.1
ICD-10 Finland
Contusion of eyeball and orbital tissues
2.2
12.7
123
556
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.3
12.7
918
7085
Z83.5
ICD-10 Finland
Family history of eye and ear disorders
7.4
12.6
29
39
CKC70
NOMESCO Finland
Circular buckling of sclera
3.7
12.6
54
147
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
2.0
12.6
164
838
SPAT1058
SPAT
PEF monitoring instruction
1.3
12.5
859
6578
37512
ICD-8 Finland
Glaucoma, Chronicum capsulare
+∞
12.5
12
*
S01EB02
ATC
carbachol; ophthalmic
+∞
12.5
12
*
SPAT1377
SPAT
Polysomnography
1.6
12.3
301
1878
CKD50
NOMESCO Finland
Endodiathermy of retina
5.8
12.3
34
59
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
12.3
2671
23295
CKC30
NOMESCO Finland
Cryopexy of detached retina
3.0
12.3
71
241
Z94.7
ICD-10 Finland
Corneal transplant status
3.5
12.3
56
161
L08
ICPC
Shoulder symptom/complaint
1.2
12.2
2034
17313
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
1.7
12.2
254
1516
S82
ICPC
Naevus/mole
1.3
12.2
1186
9527
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
2.5
12.1
95
386
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.3
12.1
1001
7874
C08CA13
ATC
lercanidipine; oral
1.2
12.1
1505
12440
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
1.7
12.1
253
1516
H53.0
ICD-10 Finland
Amblyopia ex anopsia
2.7
12.1
81
303
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
2.0
12.0
143
707
SPAT1081
SPAT
Cardiorespiratory global assessment
1.4
12.0
644
4744
C10AX09
ATC
ezetimibe; oral
1.3
11.9
1156
9276
ZXE00
NOMESCO Finland
One hour or less
1.1
11.9
4362
39594
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.3
11.9
106
461
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.4
11.9
610
4461
M45
ICD-10 Finland
Ankylosing spondylitis
1.9
11.9
181
979
R06.5
ICD-10 Finland
Mouth breathing
1.3
11.8
752
5694
A02BC02
ATC
pantoprazole; systemic
1.1
11.8
7987
75469
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
3.1
11.8
64
210
H19.8*E85.80
ICD-10 Finland
Reticular keratitis in Meretoja's patients
14.6
11.8
19
13
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
2.4
11.7
99
419
S01FA01
ATC
atropine; ophthalmic
3.2
11.7
61
194
L57.0
ICD-10 Finland
Actinic keratosis
1.3
11.7
1116
8942
S01KA02
ATC
hypromellose; ophthalmic
1.8
11.6
208
1188
H18.8
ICD-10 Finland
Other specified disorders of cornea
2.8
11.6
73
262
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
6.0
11.6
31
52
-69
ICPC
Other reason for encounter NEC
1.5
11.6
395
2672
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.3
11.6
778
5940
H15.1
ICD-10 Finland
Episcleritis
2.1
11.5
134
656
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
2.8
11.5
72
257
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.5
11.5
362
2407
H40.2
ICD-10 Finland
Primary angle-closure glaucoma
+∞
11.5
11
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.1
11.4
4125
37376
J01CA04
ATC
amoxicillin; systemic
1.1
11.4
9545
91324
Q15.0
ICD-10 Finland
Congenital glaucoma
120.1
11.4
12
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.3
11.4
781
5982
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.3
11.4
1137
9159
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.2
11.4
1531
12758
Z01.9
ICD-10 Finland
Special examination, unspecified
1.4
11.2
546
3957
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.2
11.1
1390
11492
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.1
11.1
3692
33247
SPAT1053
SPAT
Memory test
1.2
11.1
1807
15341
H02.3
ICD-10 Finland
Blepharochalasis
1.3
11.1
688
5190
S01FA02
ATC
scopolamine; ophthalmic
2.3
11.1
100
437
XQ848
NOMESCO Finland
Dermatological photography
1.6
11.0
251
1543
205
Kela drug reimbursment
Chronic hypertension
1.2
11.0
3437
30815
A02BC01
ATC
omeprazole; systemic
1.2
11.0
3158
28136
XJH00
NOMESCO Finland
Transanal ultrasonography
1.4
10.9
577
4245
TPH04
NOMESCO Finland
Cathetrisation of vein
1.2
10.9
2227
19308
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.4
10.8
559
4095
TCA15
NOMESCO Finland
Retrobulbar therapeutic injection into orbit
28.0
10.7
14
5
H44.4
ICD-10 Finland
Hypotony of eye
21.4
10.7
15
7
KMAK
NOMESCO Finland
NA
1.1
10.7
5362
49604
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.2
10.6
1964
16867
H02AB06
ATC
prednisolone; systemic
1.1
10.6
5391
49904
Z2221
NOMESCO Finland
Medical doctor
0.9
10.5
2323
26405
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
4.6
10.5
35
76
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
10.5
2475
21695
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.2
10.5
1145
9320
H3603, E107
ICD-10 Finland
NA
9.1
10.5
21
23
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.3
10.4
743
5726
CHB30
NOMESCO Finland
Goniotomy
+∞
10.4
10
*
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
2.3
10.4
94
415
L04AX01
ATC
azathioprine; systemic
1.5
10.3
379
2603
CWD00
NOMESCO Finland
Reoperation for superficial heamorrhage in eye and adjacent structures
18.8
10.2
15
8
L86
ICPC
Back syndrome with radiating pain
1.4
10.2
541
3979
K07.60
ICD-10 Finland
Snapping jaw
1.5
10.2
360
2455
M02AA07
ATC
piroxicam; topical
1.1
10.1
4361
39908
H33.4
ICD-10 Finland
Traction detachment of retina
4.5
10.1
34
75
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
2.4
10.0
80
332
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.3
10.0
740
5732
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
3.1
10.0
53
172
H02
ICPC
Hearing complaint
1.2
10.0
1338
11137
C07AB02
ATC
metoprolol; systemic
1.2
10.0
2446
21507
A10BA02
ATC
metformin; oral
1.1
9.9
3132
28056
M54.5
ICD-10 Finland
Low back pain
1.1
9.9
3391
30548
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
3.6
9.9
43
120
G44.2
ICD-10 Finland
Tension-type headache
1.2
9.9
1218
10047
UKC02
NOMESCO Finland
Cystoscopy
1.2
9.9
1692
14424
D07AA02
ATC
hydrocortisone; topical
1.2
9.9
1210
9975
TPH07
NOMESCO Finland
Cathetrisation of artery
1.2
9.8
1066
8671
CHC10
NOMESCO Finland
Peripheral iridectomy
26.0
9.8
13
5
E85.80
ICD-10 Finland
Meretoja sick
8.7
9.7
20
23
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
9.7
825
6518
JL9AE
NOMESCO Finland
Ultrasound examination of pancreas transplant
55.0
9.6
11
*
R01BA52
ATC
pseudoephedrine, combinations; oral
1.1
9.6
3257
29311
H33.5
ICD-10 Finland
Other retinal detachments
2.4
9.6
77
321
J01AA02
ATC
doxycycline; systemic
1.1
9.6
9684
93117
SPAT1043
SPAT
Audiometry
1.2
9.6
1166
9608
CFD10
NOMESCO Finland
Repair of conjunctiva
7.1
9.5
22
31
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
9.5
1757
15087
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.1
9.4
5114
47413
C10AA03
ATC
pravastatin; oral
1.3
9.4
778
6117
3711
FHL
Cyclodiateria or cryocoagulation
100.1
9.4
10
*
C02AC05
ATC
moxonidine; oral
1.4
9.4
458
3327
R03AC02
ATC
salbutamol; inhalant
1.1
9.4
5782
54003
3656X
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]
+∞
9.4
9
*
L03
ICPC
Low back symptom/complaint
1.2
9.3
2470
21843
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
1.5
9.2
262
1706
H18.4
ICD-10 Finland
Corneal degeneration
3.0
9.2
51
172
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
1.6
9.2
222
1386
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.2
9.2
1465
12408
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.5
9.2
268
1754
C09CA06
ATC
candesartan; oral
1.2
9.2
2273
19986
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.4
9.2
391
2775
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
3.3
9.1
43
129
R06AE07
ATC
cetirizine; oral
1.1
9.1
4596
42404
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.2
9.1
984
8000
R06.0
ICD-10 Finland
Dyspnoea
1.1
9.1
2763
24664
CKC65
NOMESCO Finland
Removal of buckling implant from sclera
7.7
9.1
20
26
H54.4
ICD-10 Finland
Blindness, monocular
3.9
9.1
35
89
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
1.6
9.0
209
1290
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.2
9.0
1594
13626
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.2
9.0
1005
8202
H26.1
ICD-10 Finland
Traumatic cataract
3.4
9.0
41
120
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.3
8.9
568
4308
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.3
8.9
677
5264
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
18.6
8.9
13
7
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
1.5
8.9
259
1697
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.3
8.9
641
4952
J01MA02
ATC
ciprofloxacin; systemic
1.1
8.9
4385
40394
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
1.7
8.9
179
1068
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
5.4
8.9
25
46
CJG15
NOMESCO Finland
Extraction of dislocated lens with implantation of artificial lens in anterior chamber and iridectomy or iridotomy
7.9
8.8
19
24
S06.0
ICD-10 Finland
Concussion
1.2
8.8
928
7525
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.2
8.8
2564
22818
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.3
8.8
711
5579
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.3
8.8
707
5544
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
4.9
8.8
27
55
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
2.1
8.8
90
422
L04AA06
ATC
mycophenolic acid; systemic
1.8
8.8
143
799
L60.0
ICD-10 Finland
Ingrowing nail
1.4
8.7
374
2657
S05.0
ICD-10 Finland
Injury of conjunctiva and corneal abrasion without mention of foreign body
1.8
8.7
150
852
M54.6
ICD-10 Finland
Pain in thoracic spine
1.3
8.7
564
4289
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.4
8.7
482
3579
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.1
8.7
2674
23890
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.2
8.6
968
7904
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
1.7
8.6
180
1084
H18.2
ICD-10 Finland
Other corneal oedema
4.2
8.6
31
74
WX402
NOMESCO Finland
General anaesthesia
1.2
8.6
1538
13158
J01FF01
ATC
clindamycin; systemic
1.1
8.6
2796
25066
CKD95
NOMESCO Finland
Extended combined vitectomy and lens procedure through pars plana
3.4
8.6
39
114
SCC01
NOMESCO Finland
Simple fluorination of mouth or other corresponding procedure
1.5
8.6
241
1564
CJF15
NOMESCO Finland
Secondary implantation of skleral fixed artificial lens in posterior chamber
5.2
8.6
25
48
R03BA08
ATC
ciclesonide; inhalant
1.3
8.5
737
5834
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
2.7
8.5
54
197
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.2
8.4
967
7918
3702
FHL
Trabeculotomy
90.1
8.4
9
*
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.3
8.4
685
5380
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.4
8.4
425
3109
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
1.7
8.4
167
995
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.2
8.3
1248
10502
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.2
8.3
1111
9243
CHD30
NOMESCO Finland
Laser trabeculectomy
+∞
8.3
8
*
H35.9
ICD-10 Finland
Retinal disorder, unspecified
2.6
8.3
57
218
H35.4
ICD-10 Finland
Peripheral retinal degeneration
2.2
8.3
76
339
R53
ICD-10 Finland
Malaise and fatigue
1.2
8.3
2108
18567
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
1.7
8.3
176
1066
N06AX21
ATC
duloxetine; oral
1.2
8.3
962
7892
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.3
8.2
619
4810
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
4.1
8.2
30
73
C07AA05
ATC
propranolol; systemic
1.2
8.2
1809
15753
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
1.6
8.2
210
1334
HAMTE
NOMESCO Finland
NA
2.2
8.2
81
375
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.3
8.2
473
3538
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.3
8.2
600
4648
H35.37
ICD-10 Finland
Macular holes
1.8
8.2
136
766
D06BX01
ATC
metronidazole; topical
1.2
8.1
1003
8278
SPAT1210
SPAT
Application of cast or individual aid
1.4
8.1
394
2863
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
2.8
8.1
49
176
CG2S4
NOMESCO Finland
Photography of cornea
2.8
8.1
48
170
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.1
8.1
2395
21328
S04
ICPC
Lump/swelling localized
1.3
8.1
819
6613
SPAT1131
SPAT
Colonoscopy
1.4
8.1
315
2199
M01AX01
ATC
nabumetone; oral
1.4
8.0
440
3265
H33.1
ICD-10 Finland
Retinoschisis and retinal cysts
2.4
8.0
64
269
J05AB01
ATC
aciclovir; systemic
1.2
8.0
2116
18685
R01AD01
ATC
beclometasone; nasal
1.2
8.0
1463
12546
M01AX05
ATC
glucosamine; oral
1.1
7.9
2522
22567
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.3
7.9
783
6303
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
3.8
7.9
31
81
F13
ICPC
Eye sensation abnormal
1.5
7.9
227
1487
L88
ICPC
Rheumatoid/seropositive arthritis
1.4
7.9
363
2614
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
3.4
7.9
36
107
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
2.8
7.8
48
174
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
3.4
7.8
35
102
H17.8
ICD-10 Finland
Other corneal scars and opacities
3.9
7.8
30
77
NH3EA
NOMESCO Finland
Feet X-ray examination with load
1.6
7.8
180
1117
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
2.7
7.8
48
175
EBA10
NOMESCO Finland
Surgical removal of tooth
1.2
7.8
801
6480
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
2.2
7.8
71
319
F28
ICPC
Limited function/disability (F)
2.4
7.8
59
242
XKD00
NOMESCO Finland
Uroflowmetry
1.2
7.7
1524
13145
A28
ICPC
Limited function/disability NOS
1.2
7.7
1674
14557
CGG60
NOMESCO Finland
Reinforcement of sclera using graft
45.0
7.7
9
*
XCH00
SPAT
NA
15.0
7.7
12
8
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.2
7.6
1332
11368
SPAT1211
SPAT
Application of soft bandage
1.2
7.6
891
7312
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.1
7.6
2719
24505
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.2
7.6
1297
11047
SPAT1240
SPAT
Therapeutic discussion
1.3
7.6
754
6071
SPAT1307
SPAT
Psychosocial counselling and guidance
1.4
7.6
340
2440
WX702
NOMESCO Finland
Supraglottic ventilation device
1.3
7.6
471
3566
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.5
7.5
212
1383
L16
ICPC
Ankle symptom/complaint
1.2
7.5
907
7470
R05
ICD-10 Finland
Cough
1.2
7.5
1982
17497
CK2Y4
NOMESCO Finland
OCT video recording of ocular fundus
2.6
7.5
52
201
J01AA07
ATC
tetracycline; systemic
1.2
7.5
1263
10750
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
7.5
1858
16330
WX780
NOMESCO Finland
Remote monitoring CPAP
1.4
7.5
296
2076
SPAT1094
SPAT
Continuous Positive Airway Pressure
1.9
7.4
105
563
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.4
7.4
24
647
H44.2
ICD-10 Finland
Degenerative myopia
3.9
7.4
28
71
M54.2
ICD-10 Finland
Cervicalgia
1.3
7.4
614
4837
Z97.8
ICD-10 Finland
Presence of other specified devices
2.5
7.4
55
220
H47.2
ICD-10 Finland
Optic atrophy
2.8
7.4
44
157
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.3
7.4
626
4949
H44.1
ICD-10 Finland
Other endophthalmitis
5.0
7.4
22
44
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
1.6
7.4
193
1235
R06AE09
ATC
levocetirizine; oral
1.2
7.4
1244
10591
H54.6
ICD-10 Finland
Moderate visual impairment, monocular
3.2
7.4
36
113
R02
ICPC
Shortness of breath/dyspnoea
1.2
7.4
1208
10255
SPAT1285
SPAT
Provision of consultation response
1.3
7.3
506
3891
N05BA04
ATC
oxazepam; oral
1.1
7.3
2564
23079
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
2.2
7.3
72
333
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
1.7
7.3
127
729
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.1
7.3
3557
32663
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
8.3
7.3
15
18
G04CA01
ATC
alfuzosin; oral
1.2
7.3
983
8191
M01AH05
ATC
etoricoxib; oral
1.1
7.3
6530
61907
SLT
NOMESCO Finland
NA
+∞
7.3
7
*
3651D
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA PIGMENTOSUM]
+∞
7.3
7
*
S01EB03
ATC
ecothiopate; ophthalmic
+∞
7.3
7
*
H221, M083
ICD-10 Finland
NA
+∞
7.3
7
*
3703
FHL
Laser operation on ventricular angle under general anesthesia
+∞
7.3
7
*
3652B
ICD-9 Finland
Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]
+∞
7.3
7
*
CFW10
NOMESCO Finland
Conjunctival manipulation with a needle (needling)
+∞
7.3
7
*
WZA90
NOMESCO Finland
Other doctors statement
1.1
7.3
2195
19557
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
10.8
7.3
13
12
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.3
7.3
591
4647
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
1.4
7.2
280
1952
SPAT1229
SPAT
Assessment of need for aid
1.2
7.2
846
6943
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.1
7.2
2410
21621
Z3226
NOMESCO Finland
Physiotherapist
0.9
7.2
1498
17144
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
2.4
7.2
58
245
CDC00
NOMESCO Finland
Enucleation of eye
15.7
7.2
11
7
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.1
7.2
2211
19726
R3120
NOMESCO Finland
Training in mobility skills
5.8
7.2
19
33
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.1
7.2
5325
49995
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.2
7.1
1684
14747
H3603, E109
ICD-10 Finland
NA
7.9
7.1
15
19
F16
ICPC
Eyelid symptom/complaint
1.3
7.1
408
3052
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.4
7.1
281
1974
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.6
7.1
144
2219
3793A
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]
6.0
7.1
18
30
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.2
7.0
938
7805
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
2.5
7.0
51
205
CJG40
NOMESCO Finland
Extraction of dislocated lens with implantation of artificial scleral fixed lens in posterior chamber and iridectomy or iridotomy
8.8
7.0
14
16
H50.1
ICD-10 Finland
Divergent concomitant strabismus
2.3
7.0
62
273
S08
ICPC
Skin colour change
1.3
7.0
467
3572
H53.2
ICD-10 Finland
Diplopia
1.4
7.0
264
1833
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.2
7.0
1394
12035
3643
FHL
Vitrectomy through pars Plana
4.3
7.0
24
56
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
1.5
7.0
233
1581
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.3
7.0
11
415
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.3
6.9
411
3090
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.2
6.9
815
6696
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
2.2
6.9
67
310
-1
SPAT
NA
1.4
6.9
274
1924
CKD00
NOMESCO Finland
Puncture of vitreous body for decompression
13.8
6.9
11
8
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.2
6.8
1385
11975
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.4
6.8
368
2725
WX723
NOMESCO Finland
CPAP therapy
1.4
6.8
260
1815
SPAT1101
SPAT
Orthostatic test
1.3
6.8
462
3548
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
2.4
6.8
55
234
S01XA18
ATC
ciclosporin; ophthalmic
2.3
6.8
58
254
N05CF01
ATC
zopiclone; oral
1.1
6.8
3699
34164
K85
ICPC
Elevated blood pressure
1.2
6.7
1634
14332
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.2
6.7
1639
14381
H35.8
ICD-10 Finland
Other specified retinal disorders
2.4
6.7
54
227
G45.3
ICD-10 Finland
Amaurosis fugax
1.6
6.7
178
1146
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.2
6.7
903
7522
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.8
6.7
702
8515
H35.7
ICD-10 Finland
Separation of retinal layers
2.0
6.7
80
405
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.2
6.7
920
7685
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.3
6.7
540
4248
K03.64
ICD-10 Finland
Dental calculus supragingival
1.1
6.7
2468
22280
S01GX08
ATC
ketotifen; ophthalmic
1.4
6.7
275
1944
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
2.2
6.7
60
269
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.1
6.6
5551
52371
M65.3
ICD-10 Finland
Trigger finger
1.4
6.6
369
2748
Z37.0
ICD-10 Finland
Single live birth
0.7
6.6
146
2215
K04.00
ICD-10 Finland
Hyperemia of pulp
1.4
6.6
272
1924
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
1.5
6.6
188
1231
H44.0
ICD-10 Finland
Purulent endophthalmitis
4.4
6.6
22
50
E000002
ATC
NA
1.2
6.6
963
8085
-
ICD-10 Finland
NA
1.5
6.6
227
1548
WX290
NOMESCO Finland
Other blockade of nerve
1.1
6.6
3913
36282
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.4
6.6
276
1959
CJF50
NOMESCO Finland
Removal and implantation of artificial lens in posterior chamber
7.8
6.6
14
18
S94
ICPC
Ingrowing nail
1.7
6.6
136
823
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
0.9
6.6
1907
21327
L04AB04
ATC
adalimumab; parenteral
1.7
6.6
134
809
SAAJP
NOMESCO Finland
NA
3.9
6.4
24
61
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.3
6.4
637
5135
FC1AC
NOMESCO Finland
Angiography of thoracal aortta
2.1
6.4
68
326
196
Kela drug reimbursment
Paricalcitol and cinacalcet
2.6
6.4
42
159
M48.0
ICD-10 Finland
Spinal stenosis
1.2
6.4
1333
11550
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.2
6.4
984
8306
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
3.0
6.4
34
115
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
2.1
6.3
68
330
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
4.9
6.3
19
39
Y0291
ICD-8 Finland
Examination of the nervous system and sensory organs, Eye
6.5
6.3
15
23
E10.09
ICD-10 Finland
Insulin-dependent diabetes mellitus - With coma
6.5
6.3
15
23
171
Kela drug reimbursment
Degludekinsuliini
3.4
6.3
28
83
0147
NOMESCO Finland
NA
11.0
6.3
11
10
N06AA09
ATC
amitriptyline; systemic
1.2
6.3
1045
8887
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.2
6.3
1039
8833
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.3
6.3
391
2969
YHMAS
NOMESCO Finland
NA
2.1
6.3
65
311
A10BX01
ATC
guar gum; systemic
1.3
6.3
401
3053
H50.52
ICD-10 Finland
Exophoria
2.0
6.3
76
386
37598
ICD-8 Finland
Glaucoma, Aliud definitum
+∞
6.2
6
*
3719
FHL
Other measure in this category
+∞
6.2
6
*
165
Kela drug reimbursment
Preservative-free combination of bimatoprost and timolol
+∞
6.2
6
*
CHD20
NOMESCO Finland
Posterior sclerotomy
26.7
6.2
8
*
S01AX11
ATC
[U] ofloxacin; ophthalmic
1.4
6.2
317
2333
N04BC05
ATC
pramipexole; oral
1.2
6.2
738
6075
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.3
6.2
418
3208
P20
ICPC
Memory disturbance
1.2
6.2
1350
11742
QDH
NOMESCO Finland
Operations on toe nails
5.0
6.2
18
36
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
1.7
6.2
125
755
H01
ICPC
Ear pain/earache
1.2
6.1
855
7151
K03.0
ICD-10 Finland
Excessive attrition of teeth
1.4
6.1
235
1641
R20.2
ICD-10 Finland
Paraesthesia of skin
1.3
6.1
524
4157
127
Kela drug reimbursment
Transplant complication
1.7
6.1
108
624
N06
ICPC
Sensation disturbance other
1.9
6.1
83
440
R51.81
ICD-10 Finland
Facial pain NOS
1.5
6.1
180
1190
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.2
6.1
698
5725
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
2.1
6.1
61
288
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.2
6.1
754
6235
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.3
6.0
404
3100
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
1.6
6.0
140
873
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.2
6.0
811
6763
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.5
6.0
43
171
WW200
SPAT
NA
1.2
6.0
880
7398

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
6420
49933
1.48
117.07
4.7
4.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
4826
35509
1.52
115.11
4.9
4.4
estimate
0.0
0.0
0.22
1574
11507
(3044889) 12 lead EKG panel
10918
94745
1.49
109.50
4.4
4.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
13428
122444
1.62
101.62
7.0
6.2
mmol/mol
41.2
40.2
22.13
12302
111901
(3019150) Specific gravity of Urine by Refractometry
3970
28946
1.50
95.29
4.9
4.5
kg/l
1.0
1.0
0.20
528
4501
(3023103) Potassium [Moles/volume] in Serum or Plasma
14632
137071
1.85
93.57
19.8
18.7
mmol/l
4.0
4.0
6.33
14267
133374
(3035350) Ketones [Presence] in Urine by Test strip
7915
65777
1.40
92.38
4.4
4.0
estimate
0.0
0.0
1.08
1601
11816
(3019550) Sodium [Moles/volume] in Serum or Plasma
14596
136772
1.82
91.25
19.7
18.5
mmol/l
139.6
139.6
1.24
14246
133305
(3009261) Glucose [Presence] in Urine by Test strip
7978
66838
1.39
86.25
4.4
4.0
estimate
0.0
0.0
0.01
1587
11740
(3021601) Nitrite [Presence] in Urine by Test strip
7885
66074
1.38
84.33
5.6
5.3
estimate
0.0
0.0
1.84
1635
11947
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
14702
138506
1.82
84.06
11.8
11.1
u/l
25.0
25.3
1.39
14127
132966
(40761511) CBC panel - Blood by Automated count
14341
134179
1.70
83.84
17.2
15.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
14100
131365
1.65
83.59
5.7
5.2
mmol/l
2.7
2.7
5.63
12770
119445
(3002385) Erythrocyte distribution width [Ratio]
11763
105587
1.44
82.84
20.1
19.4
%
13.8
13.8
1.75
11469
103295
(3010813) Leukocytes [#/volume] in Blood
15046
142929
1.98
81.77
25.1
23.4
e9/l
6.7
6.8
0.28
14590
138292
(3000963) Hemoglobin [Mass/volume] in Blood
15046
142930
1.98
81.75
25.2
23.5
g/l
133.5
133.6
0.24
14819
140577
(3026361) Erythrocytes [#/volume] in Blood
15044
142911
1.98
81.64
25.1
23.4
e12/l
4.4
4.4
2.16
14607
138267
(3035941) MCH [Entitic mass]
15042
142889
1.98
81.58
24.9
23.3
pg
30.4
30.3
1.67
14812
140527
(3024731) MCV [Entitic volume]
15043
142902
1.98
81.57
25.0
23.3
fl
91.4
91.4
0.17
14812
140542
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
13820
128290
1.59
81.29
5.1
4.7
mmol/l
4.6
4.6
3.61
12648
117115
(3007461) Platelets [#/volume] in Blood
15037
142850
1.97
81.16
25.1
23.4
e9/l
248.5
249.2
0.66
14668
138680
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
13690
127153
1.55
76.46
5.0
4.6
mmol/l
1.5
1.5
0.62
12363
115389
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
13133
120990
1.49
75.49
5.4
5.0
mu/l
2.3
2.1
0.37
11827
109554
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
11294
101333
1.40
74.21
4.5
4.1
pmol/l
15.1
15.0
5.41
10100
91107
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
13761
128210
1.54
73.01
5.3
4.9
mmol/l
6.1
6.0
11.26
12297
115560
(3012516) Albumin [Mass/volume] in Urine
5279
42407
1.37
68.75
3.6
3.2
mg/l
610.4
400.4
1.82
3237
26131
(3020682) Albumin/Creatinine [Ratio] in Urine
5508
44714
1.35
66.43
4.4
3.9
mg/mmol
9.3
8.9
0.26
3395
27389
(40760892) CBC W Ordered Manual Differential panel - Blood
3600
27297
1.41
65.90
4.7
4.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
5394
43696
1.35
65.78
3.5
3.1
mmol/l
7.0
7.1
1.71
4526
36139
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
3968
30617
1.39
65.53
1.8
1.7
pmol/l
60793945.7
27868235.3
1.79
3201
24810
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
13928
130822
1.52
63.46
16.5
15.9
mg/l
23.5
24.7
3.85
11236
105523
(40761536) Microorganisms panel - Urine sediment
1671
11010
1.58
61.18
4.5
4.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
11055
100000
1.35
60.85
4.7
4.3
mm/h
13.4
13.6
0.66
10162
91748
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1432
9106
1.63
60.80
6.3
7.0
mmol/l
24.5
24.7
0.84
1313
8476
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
13166
122884
1.42
56.54
4.5
4.1
mmol/l
1.3
1.3
0.07
11813
110478
(3018418) pH of Serum or Plasma
5269
43331
1.32
55.42
4.5
4.1
ph
7.4
7.4
0.70
1077
7958
(3041096) Erythrocytes [Presence] in Urine by Automated
4262
34070
1.34
54.25
4.0
3.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
792
4458
1.82
52.23
5.4
6.0
mmol/l
1.3
1.3
0.95
701
3938
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
4413
35621
1.33
52.14
1.8
1.6
mmol/l
1.3
1.3
1.86
3445
29641
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
11521
105741
1.33
51.58
7.7
7.7
u/l
77.7
79.6
4.09
10774
99146
(3037467) Urinalysis macro (dipstick) panel - Urine
10342
93649
1.30
50.37
5.1
4.7
—
—
—
0
0
(3039000) Anion gap in Blood
607
3200
1.93
49.11
5.9
6.8
mmol/l
11.3
11.2
0.23
549
2865
(3018572) Chloride [Moles/volume] in Blood
607
3201
1.93
49.07
5.9
6.8
mmol/l
104.7
105.0
0.97
549
2866
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
5243
43744
1.30
47.65
2.8
2.5
u/l
59.0
58.9
0.05
4802
40079
(3031040) Bacteria [#/volume] in Urine by Automated count
10049
91005
1.28
46.97
5.2
4.9
e6/l
1762.7
1781.5
0.01
219
1318
(3013826) Glucose [Moles/volume] in Serum or Plasma
9056
81299
1.26
43.82
5.1
4.7
mmol/l
6.9
6.8
8.20
8482
76343
(3024561) Albumin [Mass/volume] in Serum or Plasma
7096
62210
1.25
40.90
5.0
4.7
g/l
35.3
35.0
2.46
6511
57375
(3019060) Gas panel - Arterial blood
1405
9734
1.49
39.91
4.4
4.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
6736
58841
1.25
39.61
10.8
9.6
inr
1.3
1.3
0.18
2250
15907
(40761535) Cells panel - Urine sediment
1648
11843
1.44
38.63
3.8
3.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
8126
72607
1.24
38.56
7.1
6.7
mmol/l
1.2
1.2
0.17
6640
61019
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1950
14507
1.39
37.44
3.6
3.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
3307
26775
1.30
35.68
1.3
1.2
u/ml
1.7
1.8
0.07
959
6747
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
6221
54531
1.23
33.42
4.2
3.8
ng/l
73.6
65.8
0.15
4571
39477
(3007930) Methemoglobin/Hemoglobin.total in Blood
908
5993
1.55
32.28
5.2
5.1
%
0.9
0.9
2.73
842
5618
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
6505
57464
1.22
31.92
2.5
2.2
nmol/l
79.1
79.4
0.43
5763
50685
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
7366
65965
1.22
31.31
6.1
5.9
mmol/l
1.2
1.2
0.77
6648
59282
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
5065
43744
1.23
30.54
2.2
2.1
u/l
201.4
206.3
0.14
4690
40718
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
912
6103
1.52
30.41
5.2
5.0
%
1.7
1.6
1.90
846
5723
(1761868) Lipid panel - Serum or Plasma
4712
40441
1.23
30.03
3.4
3.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
6167
54457
1.22
29.63
3.1
2.9
ug/l
132.1
142.6
2.53
5594
49730
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1587
11856
1.38
29.27
2.0
2.2
nmol/l
382.8
377.8
0.34
1442
10809
(3000850) Epithelial cells [#/volume] in Urine
3562
29858
1.25
27.76
2.9
2.7
e6/l
5.2
5.6
1.05
3118
26030
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1695
12936
1.35
27.16
1.5
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
5243
46036
1.21
25.57
3.5
3.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
3794
32268
1.23
25.48
4.5
3.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
7984
72864
1.19
25.38
5.7
6.2
umol/l
11.3
11.5
0.76
7504
68998
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1713
13224
1.33
25.30
3.4
2.9
ng/l
187.4
219.9
2.86
1578
12127
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1469
11101
1.36
25.02
3.0
2.7
ml/min/173m2
57.9
62.4
4.54
581
4584
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1760
13713
1.32
24.31
6.3
7.6
g/l
120.8
120.0
0.91
1670
13223
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1561
11966
1.34
24.14
3.9
3.8
mmol/l
1.2
1.2
0.21
1308
10387
(3009542) Hematocrit [Volume Fraction] of Blood
12103
114991
1.22
23.85
17.7
17.3
%
38.7
39.0
2.03
7080
76928
(3007853) Bacteria identified in Skin by Aerobe culture
2006
16011
1.29
23.07
1.8
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
4140
35845
1.21
22.78
2.4
2.3
mg/l
2.9
3.1
2.42
3587
30413
(3016502) Oxygen saturation in Arterial blood
1876
14980
1.29
21.39
6.0
7.2
%
95.9
95.5
1.94
1782
14409
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2885
34003
0.81
20.86
2.4
2.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4771
42133
1.19
20.71
3.5
3.2
u/l
35.0
34.8
0.04
4453
39760
(3019309) Folate [Moles/volume] in Red Blood Cells
3399
29102
1.21
20.64
1.8
1.8
nmol/l
1277.4
1157.0
11.06
2612
21604
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1393
17863
0.76
20.63
5.1
4.7
%
33.8
33.0
1.79
894
11695
(3006315) Basophils [#/volume] in Blood
7297
66796
1.17
20.41
6.1
5.8
e9/l
0.0
0.0
0.09
6425
57021
(3013115) Eosinophils [#/volume] in Blood
7505
68933
1.17
19.91
6.3
6.0
e9/l
0.2
0.2
0.59
6714
59694
(3001604) Monocytes [#/volume] in Blood
7253
66446
1.17
19.88
6.1
5.8
e9/l
0.6
0.6
0.47
6386
56685
(3013650) Neutrophils [#/volume] in Blood by Automated count
8378
77627
1.17
19.83
8.8
9.1
e9/l
4.2
4.2
0.39
7464
67294
(3019198) Lymphocytes [#/volume] in Blood
7415
68094
1.17
19.58
6.2
5.9
e9/l
1.9
1.9
0.94
6666
59169
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
6608
60154
1.17
19.50
2.1
2.1
pmol/l
95.8
95.4
0.28
3224
30514
(3025159) Blasts/100 leukocytes in Blood
1331
10287
1.32
19.29
4.1
4.0
%
0.7
0.3
0.40
293
2674
(3017181) Myelocytes/100 leukocytes in Blood
1474
11565
1.30
19.14
4.0
4.0
%
1.0
1.0
0.33
378
3406
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
3603
31308
1.19
18.33
5.1
4.5
%
21.9
22.2
0.42
1856
16002
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
4433
39240
1.18
18.18
5.4
5.2
ug/l
2.7
3.7
3.41
3915
34984
(3020891) Body temperature
800
5772
1.41
18.01
4.4
4.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
2173
18026
1.24
17.67
8.3
7.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
760
5475
1.41
17.26
2.3
1.8
u/l
40.3
39.0
0.98
680
4717
(3003396) Base excess in Arterial blood by calculation
2027
16792
1.24
16.62
5.9
6.8
mmol/l
1.3
1.1
1.34
1504
13289
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1027
7813
1.34
16.58
7.7
9.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
219
1189
1.85
16.44
1.2
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
4929
44363
1.16
15.87
3.2
3.1
ng/l
1488.3
1536.1
0.28
4241
38277
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1434
11501
1.27
15.57
4.0
3.6
ng/l
94.6
91.6
0.50
1205
9750
(3021440) Promyelocytes/100 leukocytes in Blood
1376
10989
1.28
15.47
4.1
4.0
%
0.1
0.1
0.18
343
3157
(3002179) Metamyelocytes/100 leukocytes in Blood
1320
10491
1.28
15.42
3.8
3.9
%
0.6
0.7
0.51
265
2446
(40767503) Oxygen content in Capillary blood by calculation
457
3055
1.51
15.39
2.6
2.6
%
16.2
16.0
0.65
261
1593
(3003338) MCHC [Mass/volume]
11169
106638
1.16
15.38
22.6
20.8
g/l
332.0
331.4
9.92
11110
105765
(3008898) HLA-B27 [Presence]
481
3255
1.49
15.27
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
3904
34713
1.17
14.47
1.6
1.6
nmol/l
21.2
20.6
1.24
3302
29268
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
492
3389
1.47
14.31
2.5
2.3
ug/min
157.4
102.8
1.08
263
1958
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
2586
22268
1.19
14.09
1.3
1.3
iu/ml
35.1
38.4
0.47
853
6955
(1616796) Gas panel - Central venous blood
464
3170
1.48
14.08
3.9
3.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
6326
58306
1.14
14.04
11.3
10.0
e9/l
0.0
0.0
2.93
5322
47528
(3020961) Endomysium IgA Ab [Titer] in Serum
727
5391
1.37
13.90
1.2
1.1
titre
256.5
203.1
0.20
13
121
(3027801) Oxygen [Partial pressure] in Arterial blood
1999
16831
1.21
13.84
6.0
6.8
kpa
12.2
12.2
0.15
1896
16015
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2000
16842
1.21
13.82
6.1
6.8
kpa
5.0
5.1
3.00
1892
16043
(3022948) Iron [Moles/volume] in Serum or Plasma
2620
22675
1.19
13.41
2.8
2.5
umol/l
12.1
12.5
1.69
2406
20834
(42870588) Differential panel, method unspecified - Blood
5120
46672
1.14
13.16
6.1
5.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2431
21010
1.19
12.58
2.8
2.5
g/l
2.3
2.3
0.21
2219
19316
(3030981) Hyaline casts [#/volume] in Urine by Automated count
953
7459
1.30
12.54
3.2
2.8
e6/l
0.3
0.3
0.00
930
7276
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2537
22016
1.18
12.50
2.1
2.0
s
29.6
29.9
1.38
2450
21368
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
491
3471
1.43
12.49
2.4
1.9
mg/l
10.7
11.6
1.48
455
3187
(3010421) pH of Blood
522
3731
1.41
12.48
4.6
3.9
ph
7.4
7.4
1.44
437
3166
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1934
16397
1.20
12.38
1.8
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1928
16383
1.20
12.03
1.8
1.8
—
—
—
0
0
(3019225) pH of Specimen
1243
15183
0.80
11.98
4.3
4.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
597
4398
1.37
11.94
3.7
4.3
mmol/l
3.9
3.9
0.10
552
4137
(3037522) Nuclear Ab [Titer] in Serum
2015
17256
1.19
11.51
1.4
1.3
titre
517.0
543.6
0.26
426
3803
(3015235) Bicarbonate [Moles/volume] in Capillary blood
505
3648
1.40
11.39
3.1
3.1
mmol/l
24.5
25.0
1.36
459
3176
(3018405) Lactate [Moles/volume] in Arterial blood
679
5157
1.33
11.14
3.8
4.0
mmol/l
1.3
1.4
2.57
669
5066
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
428
3021
1.43
11.03
1.5
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
4051
44479
0.88
10.67
2.4
2.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
467
3368
1.40
10.66
2.3
2.3
g/l
127.4
127.5
0.03
391
2371
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
45
151
2.99
10.48
6.8
5.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2143
18617
1.17
10.28
6.5
5.5
mmol/l
1.0
1.0
0.39
1989
17153
(3026493) Urate [Moles/volume] in Serum or Plasma
3985
36203
1.13
10.22
2.9
2.7
umol/l
4253.0
5236.9
0.83
3410
30764
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
435
3123
1.40
10.22
1.1
1.1
u/ml
5.1
9.6
0.68
28
296
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
2400
21052
1.16
10.18
1.3
1.3
u/ml
10.8
14.2
1.55
865
7596
(3030905) Polymorphonuclear cells [#/volume] in Blood
368
2568
1.44
10.13
3.6
3.3
e9/l
4.4
4.2
1.25
368
2562
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
8610
81794
1.11
10.11
3.2
3.1
u/l
50.9
51.4
0.15
7904
75046
(3026782) Osmolality of Urine
3128
27994
1.15
10.05
3.1
2.9
mosm/kgh2o
515.7
538.9
8.03
2639
23726
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
469
3423
1.38
10.00
3.4
2.9
mg/l
1.7
1.6
0.25
425
3084
(3048689) Calprotectin [Mass/mass] in Stool
1721
14731
1.19
9.83
2.2
2.1
ug/g
134.8
146.9
0.65
1286
11377
(3008295) Osmolality of Serum or Plasma
221
1397
1.59
9.74
1.4
1.4
mosm/kgh2o
275.7
277.5
0.57
183
1039
(3007164) IgA [Mass/volume] in Serum or Plasma
2648
23469
1.15
9.74
1.5
1.5
g/l
2.5
2.5
0.54
1614
13454
(3005322) IgE [Units/volume] in Serum or Plasma
902
7242
1.26
9.70
1.3
1.3
u/ml
178.5
231.3
1.54
831
6620
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2253
19745
1.16
9.63
2.9
2.6
%
21.6
21.8
0.26
1761
16720
(3012501) Base excess in Blood by calculation
445
3244
1.38
9.57
4.8
3.9
mmol/l
2.6
2.7
0.18
325
2255
(3013290) Carbon dioxide [Partial pressure] in Blood
445
3245
1.38
9.56
4.8
3.9
kpa
5.1
5.0
0.85
437
3164
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
108
562
1.93
9.45
1.2
1.3
%
60.8
62.2
—
9
62
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
111
583
1.91
9.45
1.1
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
446
3267
1.38
9.33
4.8
4.0
kpa
8.6
8.5
0.61
438
3185
(3033658) Prothrombin time (PT) actual/Normal
3199
35383
0.88
9.19
3.9
4.0
%
89.2
88.7
0.60
3105
34502
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
3158
28441
1.14
9.13
4.2
3.9
ng/l
378.9
431.0
0.31
2564
23205
(3015377) Calcium [Moles/volume] in Serum or Plasma
5289
49144
1.11
8.99
3.1
3.4
mmol/l
2.4
2.4
2.38
4598
42058
(3028271) Lactate [Moles/volume] in Capillary blood
326
2277
1.44
8.98
1.9
1.9
mmol/l
1.7
1.7
0.44
321
2223
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
7455
70566
1.11
8.84
2.6
2.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
428
3153
1.37
8.67
3.0
2.9
kpa
8.0
8.0
0.54
402
2914
(3021901) Oxygen saturation in Capillary blood
372
2682
1.40
8.60
2.9
2.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
645
5047
1.29
8.58
1.3
1.2
u/ml
1.1
0.9
0.13
60
478
(3027273) Bicarbonate [Moles/volume] in Venous blood
878
7146
1.24
8.40
3.6
3.4
mmol/l
25.2
25.3
0.14
848
6945
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
311
2184
1.43
8.36
1.3
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
1056
8772
1.22
8.31
3.4
3.4
g/l
126.0
127.5
1.35
1024
8560
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1090
13011
0.83
8.30
2.7
2.4
u/l
42.6
48.1
0.33
904
11083
(3005719) IgG [Mass/volume] in Serum or Plasma
1163
9767
1.21
8.18
2.7
2.8
g/l
10.5
10.5
0.11
1039
8933
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
12683
123648
1.13
8.15
15.4
15.0
ml/min/173m2
75.8
76.4
2.49
10277
102336
(40768446) Kidney Pathology biopsy report
88
452
1.95
8.07
1.9
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
2108
18623
1.15
8.01
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
300
2120
1.42
7.82
1.3
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
287
2013
1.43
7.80
1.4
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2646
23797
1.13
7.69
1.9
1.9
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
242
1651
1.47
7.62
9.6
12.1
mmol/l
7.5
7.5
0.05
203
1358
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
640
5083
1.27
7.60
1.1
1.1
u/ml
0.9
4.9
—
10
74
(3025941) Bacteria identified in Stool by Culture
869
7148
1.23
7.56
1.3
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
202
1331
1.52
7.53
3.0
3.0
mg/l
68.5
45.2
0.36
140
937
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
335
2431
1.39
7.51
1.4
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
267
1862
1.44
7.50
1.3
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
483
3707
1.31
7.48
1.6
1.6
iu/ml
7.4
5.9
0.09
111
860
(3018095) Leukocytes [#/volume] in Urine
5290
49516
1.10
7.43
4.1
3.8
e6/l
102.3
112.2
0.36
4050
35143
(3000494) Fungus identified in Specimen by Culture
1792
15734
1.16
7.40
1.5
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2585
23268
1.13
7.39
3.0
3.2
mmol/l
0.8
0.8
1.04
2399
21513
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
156
975
1.61
7.34
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
1745
15334
1.15
7.12
1.3
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
159
1009
1.58
7.04
2.3
2.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1497
13021
1.17
7.00
2.5
2.4
ug/l
6.3
6.9
0.35
1304
11125
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
963
8070
1.21
6.96
2.5
2.5
—
—
—
0
0
(4062490)
192
1275
1.51
6.94
1.3
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
80
423
1.90
6.81
2.6
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
80
423
1.90
6.81
2.6
2.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
368
2758
1.34
6.77
1.4
1.4
mmol/l
59.7
62.3
0.69
307
2193
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
443
3411
1.31
6.75
1.9
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
2188
19602
1.13
6.71
2.2
2.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1466
12778
1.16
6.67
2.6
2.5
e9/l
70.0
69.4
0.25
1166
9640
(36304419) Bacteria [Presence] in Urine
4099
38055
1.10
6.65
3.4
3.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
190
1277
1.49
6.51
1.4
1.4
g/l
0.4
0.4
0.01
129
887
(3028192) IgG subclass 2 [Mass/volume] in Serum
190
1279
1.49
6.47
1.4
1.4
g/l
2.7
2.9
1.24
128
891
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
171
1129
1.52
6.39
1.4
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
4579
42814
1.10
6.36
3.7
3.3
e6/l
104.9
95.3
0.12
3700
32719
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
339
2536
1.34
6.34
6.3
5.1
iu/ml
784.7
1763.6
0.63
67
384
(3027135) IgG subclass 1 [Mass/volume] in Serum
189
1277
1.49
6.33
1.3
1.4
g/l
6.7
6.9
0.20
127
885
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
170
1124
1.52
6.32
1.2
1.3
nmol/l
1.5
1.4
0.51
152
1011
(3022096) Basophils/100 leukocytes in Blood
6398
60747
1.09
6.28
6.5
6.1
%
0.7
0.7
0.13
5965
56171
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1255
10873
1.17
6.18
1.6
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
126
786
1.61
6.06
1.4
1.5
—
—
—
0
0
(4010399)
1178
10178
1.17
6.02
1.5
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
4223
39424
1.10
6.00
4.4
4.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
3186
29337
1.11
6.00
1.8
1.7
mg/l
1.3
1.3
0.63
2433
22734
(3002030) Lymphocytes/100 leukocytes in Blood
6732
64142
1.09
5.98
6.5
6.2
%
27.1
27.1
0.11
6262
59164
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
125
781
1.61
5.98
1.4
1.5
—
—
—
0
0
(4027681)
102
605
1.69
5.97
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
257
1859
1.39
5.97
2.3
2.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
641
7798
0.81
5.97
8.0
8.5
mmol/l
24.0
24.4
2.39
574
7263
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
351
2667
1.32
5.94
1.4
1.4
e6/l
1330.3
1125.4
0.11
304
2193
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
187
2690
0.69
5.89
3.3
3.5
u/ml
40.9
40.2
0.02
178
2605
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
443
5603
0.78
5.87
4.0
3.9
mmol/l
24.9
25.0
0.28
402
5102
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
350
2665
1.32
5.84
1.4
1.4
e6/l
11.5
28.9
1.80
287
2087
(3006504) Eosinophils/100 leukocytes in Blood
6558
62504
1.08
5.69
6.5
6.1
%
2.9
2.8
0.77
6108
57756
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
58
294
1.98
5.65
1.8
1.9
mg/l
10.8
9.3
1.03
40
238
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
814
6855
1.20
5.64
2.7
2.8
%
1.3
1.2
0.75
809
6819
(3024471) HLA-A [Type]
65
345
1.89
5.55
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1924
17298
1.13
5.54
1.4
1.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
123
782
1.58
5.51
2.2
2.0
nmol/l
16.9
16.3
0.40
116
729
(3019069) Monocytes/100 leukocytes in Blood
6587
62850
1.08
5.49
6.7
6.4
%
8.8
8.7
1.18
6157
58327
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
897
7640
1.18
5.47
1.2
1.2
iu/ml
129.7
140.2
0.33
343
2815
(3000570) Elastase.pancreatic [Mass/mass] in Stool
532
4308
1.24
5.46
1.5
1.4
ug/g
259.2
271.0
0.69
329
2564
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
337
2580
1.31
5.44
3.9
3.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
717
5990
1.21
5.42
2.0
2.0
ug/l
2.2
2.3
0.09
636
5256
(3042733) HLA Ab [Presence] in Serum
64
341
1.88
5.41
5.2
5.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
897
7651
1.18
5.39
1.8
1.9
g/l
1.4
1.4
0.23
804
6906
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
944
8089
1.18
5.37
3.2
3.3
pmol/l
4.4
4.4
0.38
822
7109
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
95
571
1.67
5.34
1.1
1.1
u/l
1.0
1.1
0.61
45
270
(3030467) Casts [#/volume] in Urine by Automated count
4209
39466
1.09
5.32
3.5
3.3
e6/l
0.4
0.5
2.70
3351
29697
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
51
253
2.02
5.30
3.1
2.4
au/ml
130.5
161.2
—
7
36
(3018010) Neutrophils/100 leukocytes in Blood
6613
63175
1.08
5.27
6.4
6.0
%
58.0
57.9
0.53
6163
58519
(3051387) C reactive protein [Mass/volume] in Capillary blood
386
3032
1.28
5.15
3.7
3.7
mg/l
28.1
28.1
0.00
278
1917
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
246
3300
0.74
5.12
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
246
3300
0.74
5.12
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
467
3763
1.25
5.04
3.4
3.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
62
337
1.84
4.96
1.0
1.1
—
—
—
0
0
(4035726)
1152
13097
0.87
4.86
1.4
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
789
6720
1.18
4.85
2.7
2.8
%
0.7
0.7
1.34
750
6440
(3027945) Reticulocytes/100 erythrocytes in Blood
1869
16916
1.12
4.80
2.7
2.4
%
1.8
1.8
0.14
1636
14810
(3020779) Urea [Moles/volume] in Serum or Plasma
1429
12731
1.13
4.78
8.7
6.9
mmol/l
10.6
10.4
0.29
1344
12037
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
510
6198
0.82
4.77
1.9
2.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
108
691
1.57
4.77
2.1
2.1
ml
1858.1
1863.8
0.02
100
594
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
134
904
1.49
4.65
1.4
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
342
2686
1.28
4.62
1.3
1.2
mmol/l
3.9
3.8
0.80
325
2509
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
130
873
1.49
4.61
1.2
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
75
442
1.70
4.60
1.1
1.1
miu/ml
1633.0
1533.2
0.35
75
442
(3033923) Metanephrine [Moles/time] in 24 hour Urine
57
310
1.84
4.58
1.0
1.1
umol/24h
0.6
0.6
0.62
26
144
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
210
1543
1.37
4.55
1.4
1.5
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
72
421
1.71
4.55
2.3
2.0
%
12.4
10.6
0.39
65
381
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
10
21
4.76
4.53
1.6
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
94
591
1.59
4.49
1.2
1.6
ug/l
6.8
9.1
1.24
82
529
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
310
2414
1.29
4.49
1.3
1.3
miu/ml
159.8
212.1
2.25
122
1002
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
119
792
1.51
4.43
1.1
1.1
mg/l
274.7
285.4
0.22
103
691
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
45
229
1.97
4.42
1.6
1.6
au/ml
50.1
74.7
—
6
27
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
291
2253
1.30
4.41
1.7
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
380
3047
1.25
4.34
1.3
1.3
mg/l
514.1
538.5
0.48
363
2880
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
51
274
1.86
4.28
3.1
2.9
mg/l
6.4
7.5
0.79
38
222
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
261
2000
1.31
4.28
1.7
1.4
u/ml
114.1
121.1
0.66
74
439
(3019832) Treponema pallidum Ab [Presence] in Serum
641
5426
1.19
4.28
1.6
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
110
726
1.52
4.27
2.7
2.6
%
38.9
38.2
0.11
57
245
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
122
824
1.48
4.25
1.2
1.2
mg/l
39.6
42.3
0.32
100
689
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
472
5700
0.82
4.19
1.7
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
395
3196
1.24
4.18
1.5
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
409
3324
1.24
4.16
1.5
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
235
1787
1.32
4.09
2.0
2.0
u/l
6422.2
4338.6
0.45
69
671
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
253
1944
1.31
4.09
3.0
2.5
u/ml
571.9
2148.3
1.49
16
120
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
10
23
4.35
4.08
1.8
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
128
883
1.45
4.03
1.4
1.4
promille
1.2
1.2
0.05
110
665
(40768797) Stomach Pathology biopsy report
2122
19519
1.10
4.00
1.3
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
766
6622
1.16
3.98
4.0
4.1
%
48.5
47.8
0.34
756
6551
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
54
303
1.78
3.98
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
160
1153
1.39
3.96
1.2
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
6609
63587
1.07
3.93
4.4
4.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1401
12626
1.12
3.90
2.5
2.6
g/l
66.2
66.2
0.04
1264
11321
(36660697) Celiac disease serology panel - Serum
1101
9781
1.13
3.89
1.2
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
86
550
1.57
3.88
1.5
1.6
nmol/l
2.6
4.6
1.06
68
459
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
61
358
1.71
3.86
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
314
2505
1.26
3.80
1.9
1.7
mu/l
305.5
296.8
0.16
281
2295
(3006576) Bicarbonate [Moles/volume] in Blood
76
477
1.60
3.73
7.6
6.3
mmol/l
25.5
25.1
0.36
71
426
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
252
1962
1.29
3.73
1.3
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
164
1200
1.37
3.73
2.4
2.2
e9/l
1.1
1.1
0.38
108
739
(3045716) Anion gap in Serum or Plasma
97
644
1.51
3.72
4.1
2.3
mmol/l
9.3
9.0
0.24
56
484
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
244
1893
1.29
3.71
1.4
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
489
4097
1.20
3.71
1.8
1.7
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
235
1815
1.30
3.70
1.4
1.4
mu/l
72.3
60.6
0.37
207
1603
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
470
3927
1.20
3.68
1.9
1.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
60
356
1.69
3.67
1.2
1.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
133
944
1.41
3.63
2.2
2.0
%
70.6
72.0
0.45
124
895
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
220
1692
1.30
3.59
1.3
1.3
pmol/l
313.4
294.6
0.21
178
1286
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
130
923
1.41
3.55
2.2
1.9
%
16.0
14.7
0.40
64
384
(3042111) Morphology [Interpretation] in Bone marrow Narrative
305
2449
1.25
3.52
1.6
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
223
1725
1.30
3.49
1.2
1.3
nmol/l
—
—
—
0
0
(3019977) pH of Arterial blood
118
827
1.43
3.47
2.8
2.6
ph
7.4
7.4
0.15
36
307
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
71
447
1.59
3.47
1.2
1.4
pmol/l
15.5
16.3
0.58
59
373
(3017704) Immunofixation for Urine
117
819
1.43
3.46
1.5
1.6
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
35
179
1.96
3.46
1.5
1.4
%
76.7
73.9
0.21
27
150
(3042631) Mycobacterium sp identified in Specimen
260
2055
1.27
3.45
2.6
2.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
595
5107
1.17
3.44
2.8
2.7
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
112
779
1.44
3.44
2.4
2.4
e9/l
0.2
0.2
0.15
102
682
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
170
1269
1.34
3.43
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
373
4510
0.82
3.42
3.7
3.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
125
888
1.41
3.42
2.3
2.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
107
739
1.45
3.41
3.5
3.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
797
9049
0.87
3.37
1.7
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
251
1982
1.27
3.36
1.6
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
109
758
1.44
3.36
1.3
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
48
278
1.73
3.24
1.8
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
116
822
1.41
3.24
2.3
2.3
e6/l
522.1
510.8
0.09
101
688
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
377
3128
1.21
3.23
1.7
1.8
iu/l
5.0
7.5
0.39
109
1070
(44813793)
114
806
1.42
3.23
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
940
8376
1.13
3.22
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1306
11858
1.11
3.22
1.7
1.5
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
67
425
1.58
3.20
2.1
1.9
%
28.2
29.9
0.48
62
395
(3017446) Testosterone [Moles/volume] in Serum or Plasma
844
7475
1.14
3.18
2.1
2.1
nmol/l
11.8
12.1
0.61
738
6505
(3028679) Herpes simplex virus Ab [Presence] in Serum
75
489
1.54
3.18
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
321
2626
1.23
3.17
1.7
1.7
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
130
944
1.38
3.16
1.3
1.2
mmol/l
11.4
11.7
0.14
33
281
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
40
222
1.80
3.13
1.1
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
132
963
1.37
3.12
2.2
2.0
ug/l
2.3
2.4
0.06
109
803
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
317
2597
1.23
3.10
1.3
1.2
u/ml
46.5
47.7
0.04
37
277
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
55
336
1.64
3.07
1.1
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
578
5001
1.16
3.06
3.2
3.2
mg/l
47.9
48.6
0.02
442
4047
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
49
291
1.69
3.05
1.2
1.2
mg/l
0.8
55.8
1.26
37
220
(3034860) Kappa light chains.free [Mass/volume] in Serum
579
5012
1.16
3.05
3.2
3.2
mg/l
54.3
73.2
0.77
445
4058
(3046904) Somatotropin [Units/volume] in Serum or Plasma
8
16
5.00
3.05
1.4
2.8
mu/l
4.6
1.8
—
8
16
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1819
16830
1.09
3.04
4.1
4.1
u/l
242.5
247.3
0.72
1716
15814
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
59
923
0.64
3.04
1.6
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
559
6452
0.86
3.02
3.7
3.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
83
561
1.48
3.00
1.8
1.9
ug/l
49.3
56.2
0.99
78
548
(3026470) Cobalt [Mass/volume] in Blood
134
989
1.36
2.97
1.9
2.0
ug/l
3.8
3.8
0.02
123
863
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
244
1954
1.25
2.95
1.3
1.2
u/ml
281.0
290.6
0.21
171
1226
(3037756) Immunofixation for Serum or Plasma
394
3314
1.19
2.95
1.5
1.6
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
135
1000
1.35
2.93
1.1
1.2
mmol/l
30.5
34.7
1.65
119
838
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
561
4863
1.16
2.91
3.1
3.2
ratio
12.4
5.0
0.36
54
364
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
62
396
1.57
2.91
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
467
4000
1.17
2.84
1.6
1.7
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
20
90
2.22
2.79
6.8
4.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
57
361
1.58
2.79
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
727
6441
1.13
2.77
1.2
1.2
—
—
—
0
0
(4034850)
513
4436
1.16
2.77
10.8
10.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
339
2833
1.20
2.75
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1447
13320
1.09
2.73
1.6
1.5
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
64
421
1.52
2.67
1.4
1.4
%
22.0
18.5
0.48
56
384
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
400
4684
0.85
2.65
1.9
2.2
g/l
37.8
37.4
0.82
331
3949
(3010375) cycloSPORINE [Mass/volume] in Blood
75
512
1.47
2.63
24.7
26.7
ug/l
101.3
111.2
0.93
63
423
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
104
754
1.38
2.62
1.1
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
58
376
1.54
2.59
1.1
1.3
%
23.4
21.9
—
8
60
(3004588) Protein electrophoresis panel - Serum or Plasma
1157
10577
1.10
2.55
2.4
2.3
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
55
354
1.56
2.54
1.3
1.3
%
34.2
35.9
0.10
35
234
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
56
362
1.55
2.54
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
249
2037
1.23
2.54
1.5
1.6
g/l
0.6
0.8
2.49
167
1534
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
167
1305
1.28
2.53
1.2
1.1
iu/ml
2.3
2.0
—
5
38
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
93
666
1.40
2.53
1.2
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1460
13497
1.09
2.52
4.0
3.8
kpa
5.8
5.8
0.67
1405
13113
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
351
4133
0.85
2.50
2.0
2.3
g/l
0.0
0.0
1.23
309
3733
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
345
4067
0.84
2.50
2.0
2.4
g/l
0.0
0.0
0.00
307
3718
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
27
143
1.89
2.50
1.0
1.2
umol/24h
1.6
1.7
0.11
27
143
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
299
2497
1.20
2.48
3.7
1.6
nmol/l
0.8
0.8
0.59
247
2073
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
138
1055
1.31
2.48
1.2
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
111
823
1.35
2.46
2.4
2.1
min
485.5
498.8
0.90
81
606
(3052592) Norovirus Ag [Presence] in Stool
49
310
1.58
2.45
1.2
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1206
11070
1.10
2.45
3.3
3.2
kpa
4.7
4.5
1.49
1159
10711
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
17
76
2.24
2.43
1.1
1.1
u/l
2.4
3.6
—
5
16
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
71
488
1.46
2.43
10.9
11.7
mmol/l
0.6
0.6
1.06
65
441
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
459
3982
1.16
2.42
1.7
1.6
g/l
1.2
1.2
0.71
441
3749
(3038071) Oxygen [Partial pressure] in Mixed venous blood
45
280
1.61
2.41
11.3
8.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
114
852
1.34
2.40
1.1
1.3
u/ml
0.8
1.5
0.98
54
440
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
26
138
1.89
2.40
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
115
862
1.34
2.38
1.7
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
136
1046
1.30
2.36
1.1
1.1
u/ml
3.0
3.1
0.02
50
387
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
253
2093
1.21
2.34
1.3
1.2
—
—
—
0
0
(44790049)
184
1474
1.25
2.31
1.5
1.4
—
—
—
0
0
(44790048)
184
1474
1.25
2.31
1.5
1.4
—
—
—
0
0
(44790047)
184
1474
1.25
2.31
1.5
1.4
—
—
—
0
0
(44806118)
184
1474
1.25
2.31
1.5
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
134
1035
1.30
2.26
1.1
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
104
775
1.34
2.26
2.1
2.1
umol/l
13.4
26.7
—
5
76
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
35
208
1.68
2.25
1.5
1.2
ng/l
97.9
525.6
0.59
20
143
(3004775) Volume in Urine collected for unspecified duration
148
1159
1.28
2.25
2.5
2.2
ml
743.2
649.7
0.98
100
780
(3022493) Free Hemoglobin [Mass/volume] in Plasma
79
563
1.41
2.25
8.4
4.2
mg/l
3478.9
858.8
0.34
54
394
(3008116) Ketones [Moles/volume] in Urine by Test strip
44
278
1.58
2.24
1.5
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
1451
13485
1.08
2.23
4.0
3.8
mmol/l
2.0
2.0
0.02
1151
11005
(3001893) Eosinophils/100 leukocytes in Pleural fluid
69
481
1.44
2.22
1.4
1.4
%
2.1
2.6
0.15
53
413
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
87
632
1.38
2.22
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
986
9014
1.10
2.21
1.3
1.2
—
—
—
0
0
(3012544) pH of Venous blood
1503
14005
1.08
2.17
4.1
3.8
ph
7.4
7.4
0.28
13
62
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
14
61
2.30
2.14
1.3
1.0
%
21.2
21.1
0.04
14
56
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
14
61
2.30
2.14
1.1
1.0
%
7.9
8.6
0.36
14
56
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
14
61
2.30
2.14
1.3
1.0
%
37.8
36.1
0.80
14
56
(4024509)
119
1539
0.77
2.13
1.7
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
238
1979
1.21
2.12
1.2
1.3
nmol/l
0.6
2.0
1.03
232
1892
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
101
759
1.33
2.10
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
694
7694
0.90
2.09
1.4
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
50
332
1.51
2.07
11.0
8.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
24
131
1.83
2.07
1.1
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
130
1654
0.78
2.06
1.5
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
152
1210
1.26
2.05
1.4
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
65
456
1.43
2.05
1.1
2.0
u/ml
57366.8
48832.7
—
9
66
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
36
222
1.62
2.04
7.1
7.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2171
22922
0.94
2.04
3.2
3.0
e6/l
3.6
2.9
0.42
1296
12407
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
470
5320
0.88
2.03
1.5
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
440
3864
1.14
2.02
1.7
1.6
g/l
0.2
0.2
0.30
421
3621
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
30
177
1.70
2.01
5.3
5.4
ug/min
60.0
45.8
0.33
22
143
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
17
83
2.05
2.00
1.1
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
66
467
1.41
2.00
3.2
3.7
%
54.9
53.8
0.15
66
449
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
237
1984
1.20
1.99
1.2
1.3
nmol/l
0.2
0.2
1.12
13
152
(3051611) Lipemic interference index of Serum or Plasma
129
1634
0.79
1.98
4.1
3.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
271
3186
0.85
1.98
1.1
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
152
1217
1.25
1.97
2.0
2.2
u/field
2.1
2.2
0.01
61
469
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
77
561
1.37
1.97
1.4
1.4
%
64.4
65.5
0.10
55
471
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
18
337
0.53
1.96
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
690
6239
1.11
1.96
2.2
1.9
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
86
639
1.35
1.95
1.2
1.1
ratio
1.1
1.1
0.77
23
218
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
185
1517
1.22
1.93
1.1
1.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
9
33
2.73
1.93
4.1
3.5
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
65
463
1.41
1.91
1.4
1.3
mmol/l
3.3
3.3
0.01
58
422
(3016330) Potassium [Moles/time] in 24 hour Urine
30
180
1.67
1.91
1.1
1.3
—
86.7
—
0
6
(3024522) Salmonella sp identified in Specimen by Organism specific culture
155
1912
0.81
1.90
1.5
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
76
557
1.37
1.89
2.6
2.5
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
43
283
1.52
1.88
1.3
1.2
mmol/l
1.6
1.6
0.02
23
172
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
14
65
2.15
1.87
1.3
1.4
u/field
1.0
1.1
—
8
39
(3012494) Peanut IgE Ab [Units/volume] in Serum
37
236
1.57
1.86
1.1
1.1
u/ml
0.8
1.0
0.15
17
115
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
13
59
2.20
1.83
1.0
1.0
u/ml
0.1
0.0
—
6
38
(3010726) Horse dander IgE Ab [Units/volume] in Serum
151
1220
1.24
1.83
1.1
1.1
u/ml
2.6
1.8
0.14
35
278
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
280
2399
1.17
1.83
1.2
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
224
1885
1.19
1.81
1.1
1.1
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
12
53
2.27
1.80
1.0
1.0
u/ml
0.3
0.8
—
7
34
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
40
597
0.67
1.79
2.0
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
3459
33290
1.05
1.79
1.4
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
94
719
1.31
1.78
2.4
2.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
40
595
0.67
1.76
1.3
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
411
3637
1.13
1.73
1.3
1.3
iu/l
32.8
35.3
0.82
362
3144
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
13
61
2.13
1.71
1.0
1.0
u/ml
0.1
0.1
—
5
36
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
24
140
1.72
1.71
1.1
1.0
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
42
282
1.49
1.70
2.3
1.9
e6/l
147.0
792.1
1.39
20
152
(3049717) Cytology report of Urine Cyto stain
620
5623
1.11
1.70
2.6
2.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
88
672
1.31
1.70
1.9
1.7
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
14
68
2.06
1.69
1.3
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
675
6150
1.10
1.69
1.6
1.6
u/ml
9.0
17.7
2.11
19
160
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
40
589
0.68
1.69
2.0
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
40
589
0.68
1.69
2.0
2.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
163
1342
1.22
1.68
1.6
1.5
%
23.9
29.7
1.64
101
821
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
31
195
1.59
1.67
10.5
11.1
mmol/l
5.8
5.2
0.35
31
195
(3006442) Creatine [Moles/volume] in Serum or Plasma
107
841
1.27
1.67
1.7
1.6
umol/l
61.5
70.3
—
8
52
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1546
16378
0.94
1.64
4.0
3.9
ug/l
18.8
24.0
0.29
1272
13422
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
46
318
1.45
1.63
2.3
2.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
190
1594
1.19
1.62
1.1
1.1
u/ml
1.9
1.3
0.17
68
598
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
121
1500
0.81
1.61
3.2
3.7
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
10
43
2.33
1.60
6.4
5.7
umol/l
532.9
394.0
—
10
43
(3023430) Cat dander IgE Ab [Units/volume] in Serum
122
981
1.25
1.59
1.1
1.1
u/ml
3.4
3.2
0.06
47
366
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
162
1947
0.83
1.59
1.5
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
432
3861
1.12
1.57
1.3
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
50
354
1.41
1.57
1.5
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
67
890
0.75
1.55
4.8
3.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
61
448
1.36
1.55
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
374
3318
1.13
1.55
1.9
1.8
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
377
3347
1.13
1.54
1.3
1.3
u/ml
8.1
6.0
0.36
63
565
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
62
458
1.36
1.53
1.0
1.0
%
98.5
94.6
0.48
45
348
(37019676) Renin [Units/volume] in Plasma --supine
0
43
0.00
1.52
0.0
1.0
—
41.6
—
0
29
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
114
916
1.25
1.51
2.2
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
56
760
0.74
1.51
1.8
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
394
4411
0.89
1.51
2.0
2.3
g/l
0.1
0.0
0.22
350
4001
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
68
511
1.33
1.50
1.1
1.1
u/ml
3.8
18.8
—
5
46
(4281824)
143
1728
0.83
1.50
1.2
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
392
3496
1.12
1.50
1.2
1.2
titre
990.8
855.5
0.20
13
118
(3036525) Urea [Moles/time] in 24 hour Urine
16
86
1.86
1.50
2.6
3.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
9
184
0.49
1.49
1.4
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
56
758
0.74
1.49
1.8
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
56
758
0.74
1.49
1.8
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
56
758
0.74
1.49
1.8
1.8
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
94
740
1.27
1.48
1.1
1.1
nmol/l
13.5
7.8
0.25
16
157
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
372
3310
1.13
1.48
1.3
1.3
u/ml
19.0
4.5
0.87
38
364
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
406
3632
1.12
1.48
1.3
1.3
u/ml
31.0
42.9
0.43
29
217
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
636
5824
1.10
1.48
1.8
1.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
17
94
1.81
1.46
1.5
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
123
1001
1.23
1.46
2.1
2.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
158
1886
0.84
1.46
1.5
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
164
1951
0.84
1.46
2.1
2.1
mg/l
22.4
26.6
0.42
32
520
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
69
903
0.76
1.46
1.3
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
500
5514
0.90
1.46
3.1
3.4
u/ml
730.3
1360.8
0.59
420
4683
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
159
1896
0.84
1.46
1.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
846
7849
1.08
1.45
1.3
1.3
au/ml
51.8
51.5
0.01
37
321
(3017461) Flecainide [Moles/volume] in Serum or Plasma
16
87
1.84
1.45
1.4
1.5
umol/l
0.7
0.8
0.15
11
59
(3020356) Listeria sp identified in Specimen by Organism specific culture
9
38
2.37
1.45
1.0
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
208
1780
1.17
1.45
1.8
1.9
pmol/l
182.8
194.0
0.98
190
1660
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
30
195
1.54
1.45
1.3
1.3
u/l
21.4
220.8
0.67
18
137
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
233
2013
1.16
1.44
1.2
1.2
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
5
16
3.13
1.44
2.6
2.8
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
5
16
3.13
1.44
1.2
1.2
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
9
39
2.31
1.42
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
212
1822
1.17
1.41
1.2
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
159
1886
0.84
1.39
1.5
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
40
563
0.71
1.38
1.2
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
277
2436
1.14
1.35
1.5
1.6
—
—
—
0
0
(3013512) EKG study
4335
42170
1.04
1.35
4.2
4.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
89
706
1.26
1.35
1.4
1.3
nmol/l
1.2
1.2
0.26
67
545
(3045683) HLA typing for celiac disease panel - Blood or Tissue
79
618
1.28
1.34
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
160
1889
0.85
1.33
1.5
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
486
4423
1.10
1.32
1.3
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
72
921
0.78
1.31
3.0
3.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
26
168
1.55
1.31
1.4
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
124
1025
1.21
1.30
2.2
2.2
%
11.3
10.7
0.75
124
1025
(40762814) Titanium [Mass/volume] in Blood
18
295
0.61
1.30
2.6
2.2
ug/l
2.5
3.7
—
6
108
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
209
1809
1.16
1.29
1.6
1.5
%
64.1
58.8
1.14
126
1133
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
35
242
1.45
1.29
1.9
1.8
mmol/l
1.2
1.2
0.01
35
234
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
8
34
2.35
1.29
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
331
2955
1.12
1.29
3.3
3.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
18
2.78
1.28
1.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
5
18
2.78
1.28
1.8
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
85
676
1.26
1.28
1.6
1.5
%
5.9
3.6
0.35
23
145
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2878
27801
1.04
1.27
2.8
3.1
mmol/l
2.5
2.5
2.16
2512
24181
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
12
62
1.94
1.27
6.5
12.5
e6/l
164.6
321.2
—
7
48
(3033086) Enterovirus NOS Ab [Titer] in Serum
8
35
2.29
1.26
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
278
2461
1.13
1.25
1.3
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
137
1626
0.84
1.24
1.4
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
922
8644
1.07
1.24
2.5
2.4
au/ml
25.6
27.9
0.20
40
387
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
644
5957
1.08
1.23
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
93
751
1.24
1.23
15.8
10.5
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
18
108
1.67
1.22
3.0
3.0
pmol/l
13.8
65.8
—
5
38
(40758558) Short blood count panel - Blood
3576
34730
1.04
1.21
6.5
7.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
49
365
1.34
1.20
1.4
1.4
%
15.9
23.0
1.51
34
309
(3022689) Creatine [Moles/volume] in Urine
52
391
1.33
1.20
1.7
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
2320
22341
1.04
1.19
3.2
3.2
ug/l
0.8
0.8
0.32
1624
15575
(3017354) Segmented neutrophils/100 leukocytes in Blood
129
1533
0.84
1.19
2.9
3.4
%
62.2
58.2
1.16
73
994
(3001019) Free T4 and TSH panel - Serum or Plasma
414
4550
0.91
1.18
1.7
1.7
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
12
64
1.88
1.17
1.3
1.7
u/l
0.4
0.2
—
5
18
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
314
2814
1.12
1.17
1.2
1.2
titre
60.0
156.8
—
6
63
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
21
133
1.58
1.17
1.1
1.2
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
45
333
1.35
1.16
1.1
1.3
nmol/l
82.4
137.0
4.42
35
235
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
35
0.00
1.15
0.0
1.1
—
85.1
—
0
29
(3045424) Erythrocytes [Presence] in Urine
261
2318
1.13
1.14
1.7
1.5
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
4.5
—
4.4
—
0
27
(3050129) First trimester maternal screen panel - Serum or Plasma
83
1023
0.81
1.13
1.5
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1902
18259
1.05
1.13
6.0
6.8
mmol/l
104.0
104.3
1.78
1822
17875
(3002256) Pathology report gross observation
1752
18269
0.95
1.11
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
66
830
0.79
1.09
1.3
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
17
104
1.64
1.09
1.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
24
160
1.50
1.08
2.1
2.0
umol/l
15.7
17.3
0.28
24
160
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
115
1366
0.84
1.08
1.6
1.7
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
116
974
1.19
1.08
1.0
1.0
ng/l
801.6
711.4
0.97
70
640
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
66
829
0.80
1.08
1.3
1.4
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
7
32
2.19
1.08
1.3
1.1
mmol/l
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
383
3491
1.10
1.06
1.2
1.2
titre
94.3
159.9
1.78
35
301
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
16
97
1.65
1.06
1.3
1.5
%
28.5
37.8
—
8
65
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
744
6970
1.07
1.06
1.6
1.6
g/l
1.5
1.6
1.27
628
5934
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
116
977
1.19
1.05
1.0
1.0
ng/l
40.7
42.9
0.23
67
656
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
7
33
2.12
1.05
1.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
28
396
0.71
1.05
2.1
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
89
731
1.22
1.05
1.6
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
250
2229
1.12
1.05
1.4
1.3
u/l
11.0
12.3
0.82
212
1806
(3010503) CD19 cells [#/volume] in Blood
96
795
1.21
1.04
2.6
2.3
e9/l
0.2
0.4
0.69
91
764
(3042010) Triglyceride [Moles/volume] in Pleural fluid
31
220
1.41
1.04
1.4
1.2
mmol/l
2.5
1.4
0.30
17
143
(1617658) Protocol used for examination of sentinel lymph nodes
99
1186
0.83
1.04
1.1
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
388
3545
1.10
1.03
1.3
1.3
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
43
323
1.33
1.03
3.6
2.2
mmol/l
7.5
7.5
0.01
25
206
(3023183) Ammonium ion [Moles/volume] in Plasma
313
2830
1.11
1.03
2.5
2.5
umol/l
30.6
33.7
1.57
251
2363
(40768795) Lymph node Pathology biopsy report
126
1476
0.85
1.02
1.2
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
114
962
1.19
1.02
1.2
1.3
mmol/l
2.1
2.2
0.13
106
893
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
67
833
0.80
1.02
1.3
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
162
1407
1.15
1.02
2.4
2.6
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
115
972
1.18
1.01
1.0
1.0
ng/l
408.5
320.1
0.63
72
665
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
67
832
0.80
1.01
1.3
1.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
60
474
1.27
1.01
3.0
2.9
umol/l
29.6
27.8
0.64
49
356
(3043238) Trisomy 21 risk [Likelihood] in Fetus
56
709
0.79
1.00
1.3
1.5
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
187
1645
1.14
0.99
1.3
1.2
u/ml
32.1
58.0
1.32
17
124
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
50
388
1.29
0.97
1.2
1.2
g/l
0.3
0.3
0.50
42
308
(3034092) Cytoplasmic Ig cells/100 cells in Blood
24
165
1.46
0.96
10.5
10.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
192
1696
1.13
0.96
1.1
1.1
iu/ml
4039.9
6766.7
0.15
46
359
(3011335) Digoxin [Mass/volume] in Serum or Plasma
23
157
1.47
0.95
1.6
2.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
136
1174
1.16
0.95
1.7
1.5
u/ml
22.9
24.0
0.12
29
237
(46235355) HIV 1 and 2 tests - Meaningful Use set
1573
15112
1.05
0.94
1.8
1.6
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
17
258
0.66
0.94
3.0
3.2
ng/l
234.6
120.8
—
5
86
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
115
981
1.17
0.93
1.5
1.5
u/l
7.3
6.3
0.21
50
472
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
13
209
0.62
0.93
1.8
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
635
6771
0.94
0.93
4.7
4.1
mmol/l
24.0
24.2
0.81
546
6071
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
72
877
0.82
0.93
1.8
1.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
169
1485
1.14
0.92
1.2
1.2
mmol/l
7.8
7.6
0.46
134
1056
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
12
70
1.71
0.92
3.2
3.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
44
339
1.30
0.91
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
122
1416
0.86
0.91
1.3
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
38
287
1.32
0.90
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
155
1357
1.14
0.90
1.7
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
55
687
0.80
0.90
1.3
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
80
664
1.21
0.89
1.1
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
21
301
0.70
0.88
1.1
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
105
0.48
0.88
1.2
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
178
1576
1.13
0.88
1.4
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
58
717
0.81
0.87
1.9
1.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
711
7534
0.94
0.87
3.4
3.8
u/ml
84.4
63.8
0.20
679
7255
(3005033) Fetal Nuchal fold Thickness US
55
683
0.80
0.86
1.3
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
55
440
1.25
0.86
2.4
1.9
—
—
—
0
0
(4198724)
21
299
0.70
0.86
1.9
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
69
567
1.22
0.85
2.0
3.0
mu/l
17.1
24.6
1.84
63
528
(3035880) pH of Pleural fluid
100
851
1.18
0.85
1.4
1.3
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
16
240
0.67
0.85
1.2
1.2
%
100.6
110.7
0.57
16
225
(3033799) Differential panel - Peritoneal fluid
35
457
0.77
0.83
2.0
1.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
960
9148
1.05
0.83
7.0
8.5
%
0.7
0.7
2.36
955
9089
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
21
146
1.44
0.82
1.2
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
21
146
1.44
0.82
1.2
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
21
146
1.44
0.82
1.2
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
29
214
1.36
0.82
1.2
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
29
214
1.36
0.82
1.2
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
964
9192
1.05
0.82
7.1
8.5
%
94.1
93.8
0.88
958
9161
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
772
8141
0.95
0.82
1.8
1.8
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
6
32
1.88
0.81
8.2
9.6
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
78
653
1.20
0.81
1.1
1.1
iu/ml
3.0
3.6
—
5
37
(3005570) Glucose [Moles/volume] in Urine
135
1538
0.88
0.81
2.3
1.9
—
1.5
—
0
7
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
91
773
1.18
0.81
1.1
1.1
u/l
81.5
89.0
0.50
63
609
(21494815) CD4 cells/100 lymphocytes in Specimen
119
1033
1.15
0.80
2.1
2.1
%
43.6
41.3
0.18
16
118
(43055514) Macroprolactin [Presence] in Serum or Plasma
22
155
1.42
0.80
1.8
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
8
48
1.67
0.78
2.3
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
93
794
1.17
0.78
1.7
2.0
u/field
3.4
2.5
0.53
74
536
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
25
339
0.74
0.78
1.2
1.2
%
75.4
87.6
0.68
13
167
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
45
357
1.26
0.78
1.8
1.6
ug/l
10.1
9.1
0.69
45
357
(3044009) aPTT.lupus sensitive (LA screen)
5
96
0.52
0.78
1.0
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
98
0.51
0.77
1.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
148
1.42
0.77
1.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
99
0.50
0.77
1.0
1.2
—
—
—
0
0
(4146454)
180
1612
1.12
0.77
3.0
2.6
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
20
140
1.43
0.76
1.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
56
682
0.82
0.76
1.4
1.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
47
582
0.81
0.75
5.8
4.7
u/ml
1337.7
451.3
—
7
86
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
67
1.64
0.75
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
109
947
1.15
0.75
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
109
947
1.15
0.75
1.3
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
12
75
1.60
0.74
1.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
82
697
1.18
0.74
3.2
3.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
109
948
1.15
0.74
1.3
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
91
781
1.17
0.73
1.5
1.5
u/l
5.9
6.1
0.16
74
650
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
16
231
0.69
0.73
1.4
1.2
%
89.6
79.0
—
5
75
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
8
134
0.60
0.73
4.0
2.6
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
90
773
1.17
0.72
1.1
1.1
u/l
25.7
27.1
0.10
58
588
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
18
125
1.44
0.72
1.2
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
10
60
1.67
0.72
1.1
1.1
mmol/l
8.3
8.4
—
10
60
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
183
1649
1.11
0.72
1.2
1.2
u/l
58.9
61.9
0.27
133
1094
(3008536) Aspergillus sp Ab [Presence] in Serum
20
276
0.72
0.71
1.8
1.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
304
2808
1.08
0.71
1.3
1.2
u/ml
3.0
12.9
—
7
42
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
411
3843
1.07
0.70
1.4
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1281
12351
1.04
0.70
1.8
1.7
%
1.5
1.5
0.72
1061
10568
(3048879) Bone marrow aspiration report
37
466
0.79
0.70
1.5
1.7
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
190
1719
1.11
0.70
5.1
4.6
umol/l
375.8
357.8
0.81
168
1452
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
101
879
1.15
0.69
2.4
2.4
e6/l
711.6
629.5
0.53
43
356
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
59
706
0.84
0.69
2.3
2.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
141
1257
1.12
0.68
1.4
1.4
u/l
35.3
33.5
0.22
114
1024
(3002619) Bacteria identified in Specimen by Culture
22
296
0.74
0.68
1.5
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
19
261
0.73
0.67
1.2
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
93
0.54
0.66
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
93
1068
0.87
0.66
1.2
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
5
94
0.53
0.66
1.0
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
507
4786
1.06
0.66
1.6
1.6
titre
139.0
256.3
1.63
25
205
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
247
2271
1.09
0.66
1.3
1.3
u/l
24.2
38.1
2.73
211
1960
(3001556) Androgen free Index in Serum or Plasma
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
302
2803
1.08
0.65
1.3
1.2
u/ml
9.9
4.3
0.49
30
216
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
183
1661
1.10
0.65
1.1
1.1
au/ml
9.6
13.0
0.34
12
65
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
15
103
1.46
0.64
1.7
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
83
717
1.16
0.64
2.6
2.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
176
1595
1.10
0.64
2.3
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
684
6518
1.05
0.64
1.9
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
91
792
1.15
0.64
1.4
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
43
350
1.23
0.63
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
131
1465
0.89
0.63
1.5
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
185
1683
1.10
0.63
1.9
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
159
1759
0.90
0.63
1.7
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
28
359
0.78
0.63
1.5
1.7
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
21
155
1.36
0.62
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
107
944
1.13
0.62
1.3
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
12
79
1.52
0.62
1.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
17
121
1.41
0.62
1.1
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
107
945
1.13
0.62
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
107
945
1.13
0.62
1.3
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
50
415
1.21
0.61
1.1
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
929
8929
1.04
0.61
3.5
3.6
ph
7.4
7.4
0.82
189
1136
(3025886) Oxalate [Mass/time] in 24 hour Urine
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
147
1629
0.90
0.61
3.4
3.9
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
30
235
1.28
0.61
1.0
1.1
u/ml
4.0
12.3
—
5
35
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
66
771
0.86
0.61
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
66
771
0.86
0.61
1.3
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
43
352
1.22
0.61
1.1
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
881
8461
1.04
0.60
6.1
6.6
mmol/l
24.8
24.9
0.22
873
8378
(21494814) CD8 cells/100 lymphocytes in Specimen
61
517
1.18
0.60
2.3
1.9
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
9
141
0.64
0.60
4.9
5.7
—
—
—
0
0
(3000492) Spirometry study
1119
11585
0.96
0.59
1.5
1.5
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
10
151
0.66
0.59
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
414
3903
1.06
0.59
1.2
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
44
363
1.21
0.58
2.0
1.7
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
7
113
0.62
0.58
1.3
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
71
613
1.16
0.57
1.3
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
42
346
1.21
0.57
1.4
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
21
158
1.33
0.57
1.5
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
340
3190
1.07
0.57
1.3
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
306
3271
0.93
0.57
1.5
1.5
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
27
342
0.79
0.56
1.1
1.1
%
80.9
86.6
0.42
14
165
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
55
647
0.85
0.56
1.3
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
10
65
1.54
0.55
7.1
4.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
91
803
1.13
0.55
1.4
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
137
1239
1.11
0.55
1.1
1.2
nmol/l
348.6
339.3
0.21
116
987
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
481
5063
0.95
0.54
2.4
2.4
g/l
1.3
0.9
1.06
388
4281
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
156
1421
1.10
0.54
1.1
1.1
u/ml
2.8
3.6
0.25
71
540
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
123
0.65
0.54
2.0
1.6
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
12
82
1.46
0.54
1.2
1.6
%
17.3
13.7
—
6
59
(3006462) Nitrate [Presence] in Urine
61
707
0.86
0.53
4.6
3.6
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
24
305
0.79
0.52
1.5
1.4
mmol/l
8.6
8.5
0.08
14
172
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
65
563
1.16
0.52
1.7
1.8
umol/l
160.8
120.7
0.26
32
307
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
112
1245
0.90
0.52
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
112
1245
0.90
0.52
1.5
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
112
1245
0.90
0.52
1.5
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
315
2961
1.07
0.51
1.1
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
15
203
0.74
0.51
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
386
4077
0.95
0.51
4.5
4.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
31
380
0.82
0.50
1.3
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
9
65
1.38
0.50
1.1
1.5
umol/24h
297.7
323.9
—
9
65
(4211845)
67
767
0.87
0.50
4.3
3.5
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
43
361
1.19
0.50
1.7
1.5
g/l
13.9
13.7
0.04
28
285
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
6
41
1.46
0.50
1.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
10
67
1.49
0.49
1.0
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
935
9043
1.04
0.49
3.5
3.6
kpa
5.2
5.2
0.16
863
8294
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
53
455
1.17
0.48
1.4
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
29
356
0.81
0.48
1.2
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
62
539
1.15
0.48
3.4
2.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
329
3483
0.94
0.48
2.6
2.3
%
198.7
199.1
0.03
308
3291
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
126
1146
1.10
0.48
2.2
1.8
mg/l
3.5
4.2
1.84
120
1081
(3011325) HIV 1+2 Ab [Presence] in Serum
7
47
1.49
0.47
1.0
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
2070
20274
1.02
0.47
26.9
27.0
inr
1.5
1.4
1.25
246
2815
(3025315) Body weight
15
111
1.35
0.46
4.9
4.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
416
3960
1.05
0.46
1.2
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
49
1.43
0.46
1.0
1.0
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
5
82
0.61
0.45
1.0
1.3
—
10925.0
—
0
5
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
85
0.59
0.45
1.2
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
85
0.59
0.45
1.4
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
151
1391
1.09
0.45
1.3
1.4
e6/l
278105.1
134897.3
0.80
92
956
(3014765) Yersinia sp identified in Stool by Organism specific culture
414
3948
1.05
0.44
1.2
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
19
148
1.28
0.43
1.1
1.1
u/ml
82.8
54.8
0.62
19
141
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
107
972
1.10
0.43
1.2
1.2
u/l
91.7
85.0
0.27
89
836
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
24
193
1.24
0.43
1.1
1.4
%
57.8
52.1
—
9
89
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
56
1.43
0.42
1.1
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
91
0.66
0.42
1.0
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
104
945
1.10
0.42
1.2
1.2
u/l
19.9
23.1
0.55
85
792
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
81
726
1.12
0.42
2.4
2.1
ug/min
79.3
141.7
0.54
20
159
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
44
378
1.16
0.42
2.8
2.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
243
2287
1.06
0.42
1.4
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
55
481
1.14
0.41
1.1
1.1
iu/ml
191.6
166.6
0.24
55
474
(3022621) pH of Urine by Test strip
965
9374
1.03
0.41
3.6
3.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
30
249
1.21
0.41
1.3
1.4
%
26.0
11.2
—
8
139
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
14
105
1.33
0.41
1.1
1.1
u/l
4.6
11.5
1.62
14
105
(3021879) Hepatitis B virus core Ab [Presence] in Serum
791
7662
1.03
0.41
1.5
1.4
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
5.9
—
0.3
—
0
17
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
502
4821
1.04
0.40
1.5
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
32
268
1.19
0.40
1.1
1.1
—
—
—
0
0
(4038314)
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
101
0.69
0.39
1.4
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
505
5251
0.96
0.39
3.0
2.9
u/ml
0.3
0.4
0.19
293
2990
(3020123) Porphyrins [Interpretation] in Serum or Plasma
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
20
248
0.81
0.39
1.5
1.7
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
42
485
0.87
0.39
1.3
1.2
g/l
39.1
39.5
0.07
27
252
(3014051) Protein [Presence] in Urine by Test strip
341
3252
1.05
0.38
2.6
2.2
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
9
66
1.36
0.38
9.0
8.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
32
270
1.19
0.38
1.2
1.7
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
49
558
0.88
0.38
1.1
1.1
u/ml
4.0
6.9
—
10
83
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
98
1.33
0.37
1.0
1.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
108
992
1.09
0.37
2.6
3.6
nmol/l
165.9
150.8
0.14
108
975
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
38
327
1.16
0.37
1.5
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
94
858
1.10
0.36
1.3
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
72
648
1.11
0.36
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
144
1547
0.93
0.36
1.2
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
30
354
0.85
0.36
1.1
1.2
pmol/l
502.4
301.0
0.55
18
246
(3000093) Morphology [Interpretation] in Blood Narrative
131
1412
0.93
0.36
1.2
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
11
81
1.36
0.36
1.5
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
886
8626
1.03
0.35
3.4
3.5
mmol/l
2.2
1.9
1.26
636
6485
(3022475) Manganese [Moles/volume] in Blood
5
80
0.62
0.35
1.0
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
58
517
1.12
0.35
1.1
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
10
73
1.37
0.34
1.0
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
44
1.36
0.34
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
297
3111
0.95
0.34
1.5
1.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
57
509
1.12
0.34
1.2
1.1
ng/l
122.2
464.0
1.54
15
123
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
207
1957
1.06
0.34
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
159
1695
0.94
0.34
1.4
1.5
e6/l
84977.4
52951.5
0.32
85
995
(3004809) Band form neutrophils/100 leukocytes in Blood
256
2435
1.05
0.33
3.1
3.4
%
1.7
1.5
0.37
202
1873
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
45
1.33
0.33
1.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
152
1423
1.07
0.33
1.3
1.3
u/l
391.5
444.6
0.16
143
1342
(3000285) Sodium [Moles/volume] in Blood
17
210
0.81
0.33
1.5
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
27
318
0.85
0.33
1.1
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
6
46
1.30
0.33
40.0
13.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
120
1115
1.08
0.33
1.6
1.6
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
76
692
1.10
0.32
1.0
1.1
iu/ml
6.7
10.8
0.81
14
150
(3038177) Helicobacter pylori Ab [Presence] in Serum
202
1913
1.06
0.32
1.2
1.3
—
—
—
0
0
(4212803)
11
143
0.77
0.32
1.2
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
97
895
1.08
0.31
1.5
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
12
92
1.30
0.31
1.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
135
1263
1.07
0.31
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
132
1411
0.93
0.31
2.4
2.9
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
295
3081
0.96
0.31
1.4
1.5
pmol/l
197.5
175.8
0.21
284
3005
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
111
1031
1.08
0.31
1.4
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1570
15979
0.98
0.31
2.8
2.6
umol/l
9.3
8.7
0.43
1333
13860
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
34
295
1.15
0.31
1.2
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
176
1863
0.94
0.31
1.4
1.5
e6/l
5444.4
2311.0
0.42
132
1333
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
53
1.32
0.30
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
30
258
1.16
0.30
1.0
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1372
13465
1.02
0.30
2.0
2.2
g/l
0.2
0.2
0.28
1249
12506
(3023410) Appearance of Cerebral spinal fluid
110
1182
0.93
0.30
1.3
1.5
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
54
1.30
0.30
1.1
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
107
995
1.08
0.30
2.5
2.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
212
2016
1.05
0.30
1.9
1.8
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
56
1.25
0.29
1.1
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
29
250
1.16
0.29
1.6
1.7
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
7
57
1.23
0.29
1.0
1.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
16
195
0.82
0.28
3.3
2.7
u/field
0.3
0.7
1.97
16
195
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
21
176
1.19
0.28
1.9
2.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
8
111
0.72
0.28
2.8
2.5
umol/l
186.4
406.4
—
8
104
(3002621) Streptococcal DNAse B [Units/volume] in Serum
13
103
1.26
0.28
1.2
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
106
989
1.07
0.28
1.4
1.3
titre
44.5
63.4
0.50
11
80
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
28
242
1.16
0.27
1.8
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
97
1042
0.93
0.27
1.2
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
20
168
1.19
0.27
2.0
2.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
112
1049
1.07
0.27
1.4
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
152
1438
1.06
0.27
1.0
1.1
u/ml
3.7
3.8
0.03
66
680
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
8
66
1.21
0.26
5.4
8.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
45
500
0.90
0.26
14.2
11.4
nmol/l
804.4
831.8
0.17
39
476
(3021788) Differential panel - Synovial fluid
259
2698
0.96
0.26
1.6
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
120
1128
1.06
0.26
1.3
1.4
nmol/l
0.2
0.3
2.78
89
794
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
72
0.69
0.26
1.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
69
749
0.92
0.26
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
43
386
1.11
0.25
1.4
1.4
—
—
—
0
0
(4015189)
38
425
0.89
0.25
2.1
2.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
169
1608
1.05
0.25
1.2
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
41
456
0.90
0.25
2.5
1.8
e6/l
4360.5
13094.6
1.08
23
246
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
31
273
1.14
0.25
1.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
17
142
1.20
0.24
1.1
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
547
5612
0.97
0.24
2.3
2.3
g/l
10.2
10.2
0.11
417
4657
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
82
0.73
0.24
1.0
1.0
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
29
255
1.14
0.24
4.3
5.1
u/l
40.6
57.9
0.61
14
88
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
176
1680
1.05
0.23
1.1
1.1
g/l
1.5
1.5
0.11
162
1524
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
113
1198
0.94
0.23
1.2
1.1
%
96.3
94.3
0.32
103
1114
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
323
3126
1.03
0.23
1.3
1.4
—
—
—
0
0
(4306422)
171
1633
1.05
0.23
1.2
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
19
162
1.17
0.22
1.6
1.8
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
50
457
1.09
0.22
1.6
1.6
umol/l
2.1
2.0
0.41
45
429
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
91
0.77
0.22
1.6
2.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
93
0.75
0.22
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
87
815
1.07
0.22
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
59
544
1.08
0.22
1.5
1.4
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
94
0.74
0.22
1.1
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
102
1082
0.94
0.22
1.3
1.2
titre
81.9
172.4
2.73
16
204
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
23
200
1.15
0.22
1.2
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
501
5136
0.97
0.22
2.3
2.2
ug/l
816.2
583.0
0.24
468
4821
(3034274) Bile acid [Moles/volume] in Serum --fasting
83
777
1.07
0.22
1.4
1.7
umol/l
6.2
10.2
1.33
56
568
(3017315) Amylase [Enzymatic activity/volume] in Urine
78
729
1.07
0.21
1.0
1.2
u/l
158.5
350.8
2.60
71
676
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
309
3189
0.97
0.21
2.9
3.3
u/ml
346.9
611.6
0.79
282
2894
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
13
107
1.22
0.21
1.1
1.0
u/ml
0.1
5.3
—
6
81
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
10
0.00
0.21
0.0
1.9
—
12.1
—
0
10
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
246
2548
0.96
0.21
1.2
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
12
145
0.83
0.21
1.1
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
126.4
—
0
13
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
154
1610
0.96
0.20
1.1
1.1
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
14
117
1.20
0.20
1.1
1.1
u/ml
0.0
0.5
—
9
73
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
80
751
1.07
0.20
1.7
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
362
3720
0.97
0.20
1.8
1.7
mg/l
3.8
3.5
0.29
270
2677
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
9
112
0.80
0.20
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
278
2868
0.97
0.19
1.5
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
91
859
1.06
0.19
5.5
6.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
108
1025
1.05
0.19
1.4
1.3
titre
266.3
438.5
—
8
86
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
51
1.18
0.19
3.8
1.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
164
1574
1.04
0.19
1.2
1.1
%
122.8
118.7
0.75
142
1398
(3002331) Protein [Mass/volume] in Peritoneal fluid
28
312
0.90
0.19
1.5
1.4
g/l
23.9
26.6
0.38
22
244
(21494434) Karyotype in Bone marrow
132
1261
1.05
0.19
1.1
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
18
207
0.87
0.19
1.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
740
7531
0.98
0.18
1.3
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
16
137
1.17
0.18
1.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
366
3568
1.03
0.18
1.7
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
548
5592
0.98
0.18
2.3
2.3
g/l
3.0
3.1
1.24
369
4311
(3042517) Benzodiazepines panel - Urine
7
59
1.19
0.18
1.9
2.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
56
522
1.07
0.17
2.3
2.2
umol/l
55.9
55.4
0.06
44
410
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
25
279
0.90
0.17
1.5
1.9
ug/l
2.3
2.5
0.07
15
156
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
60
641
0.94
0.17
1.1
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
159
1650
0.96
0.17
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
1198
12128
0.99
0.16
7.1
7.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
225
2184
1.03
0.16
1.9
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
55
515
1.07
0.16
1.2
1.4
—
—
—
0
0
(4094501)
369
3608
1.02
0.16
1.1
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
73
1.10
0.15
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
37
341
1.09
0.15
1.0
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
12
140
0.86
0.15
3.0
3.0
mmol/l
9.7
7.4
—
7
71
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
33
303
1.09
0.15
1.5
1.5
ng/l
106.7
121.3
0.36
33
303
(3036782) Glucose [Moles/volume] in Pleural fluid
146
1409
1.04
0.15
1.3
1.3
mmol/l
6.7
6.4
0.67
138
1289
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
37
342
1.08
0.15
1.0
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
51
478
1.07
0.15
1.0
1.0
u/ml
0.3
1.8
1.24
15
150
(3024869) Neuronal Ab [Presence] in Serum
24
265
0.91
0.14
1.2
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
100
958
1.04
0.14
1.3
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
7
90
0.78
0.14
1.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
17
150
1.13
0.14
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
225
2190
1.03
0.14
1.9
1.8
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
26
285
0.91
0.14
2.0
2.5
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
23
208
1.11
0.14
1.3
1.3
%
20.0
24.4
0.25
12
163
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
112
1164
0.96
0.14
1.7
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2465
24813
0.99
0.13
2.9
2.9
e6/l
1.3
1.2
0.28
1592
14174
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
62
653
0.95
0.13
1.3
1.3
g/l
1.6
1.5
—
6
52
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
20
180
1.11
0.13
1.1
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
11
94
1.17
0.13
1.0
1.0
—
—
—
0
0
(44806071)
16
142
1.13
0.12
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
200
1949
1.03
0.12
1.3
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
148
0.88
0.12
1.1
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
384
3772
1.02
0.12
2.2
2.1
%
93.7
90.3
2.37
357
3514
(3001186) Copper [Moles/volume] in Serum or Plasma
25
272
0.92
0.12
1.0
1.3
umol/l
17.5
17.0
0.24
25
245
(3051101) Glucose [Moles/volume] in Cord blood
25
272
0.92
0.12
7.0
6.2
—
—
—
0
0
(44806420)
44
467
0.94
0.12
2.0
2.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1279
12678
1.01
0.12
5.6
6.5
mmol/l
1.3
1.4
0.36
1222
12212
(3004716) Salmonella sp identified in Stool by Organism specific culture
575
5673
1.01
0.11
1.4
1.4
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
49
464
1.06
0.11
1.2
1.4
%
66.2
56.1
1.28
43
396
(3038515) Glucose [Moles/volume] in Venous blood
316
3218
0.98
0.11
3.8
3.5
mmol/l
7.9
7.6
0.86
307
3156
(3027944) Amphetamines [Presence] in Urine
219
2142
1.02
0.11
1.9
1.8
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
40
424
0.94
0.10
1.3
1.3
ug/l
510.1
293.2
0.20
22
232
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
47
446
1.05
0.10
1.3
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
139
1428
0.97
0.10
1.4
1.5
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
111
1077
1.03
0.10
1.4
1.4
u/l
13.3
13.0
0.12
105
1030
(3037556) Urate [Mass/volume] in Serum or Plasma
42
443
0.95
0.10
1.3
1.4
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
42
398
1.06
0.10
1.7
1.6
ug/l
0.3
0.4
1.36
25
255
(3014599) Egg white IgE Ab [Units/volume] in Serum
48
457
1.05
0.09
1.0
1.0
u/ml
0.3
0.6
1.29
12
117
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
22
238
0.92
0.09
3.5
2.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
22
203
1.08
0.09
1.0
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
188
1920
0.98
0.09
1.2
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
102
1051
0.97
0.09
1.2
1.2
u/ml
2.0
4.5
—
8
66
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
36
340
1.06
0.09
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
142
1386
1.02
0.09
1.0
1.1
u/ml
1.1
1.1
0.06
51
551
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
6
54
1.11
0.09
1.0
1.1
nmol/l
203.7
261.6
—
6
54
(40768793) Breast Pathology biopsy report
327
3317
0.99
0.08
1.3
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
42
400
1.05
0.08
2.3
1.9
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
78
755
1.03
0.08
1.1
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
204
2003
1.02
0.08
2.6
2.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
167
1636
1.02
0.08
1.6
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
221
2172
1.02
0.08
1.9
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
334
3385
0.99
0.08
3.6
3.4
mmol/l
1.5
1.6
1.87
324
3314
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
67
693
0.97
0.08
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
171
1743
0.98
0.08
1.3
1.2
u/ml
4.3
4.0
0.07
58
565
(3013293) Extractable nuclear Ab [Presence] in Serum
22
205
1.07
0.07
1.6
1.6
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
70
0.86
0.07
1.5
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
211
2144
0.98
0.07
1.4
1.2
—
—
—
0
0
(3036603) Volume of Urine
96
936
1.03
0.07
1.8
1.6
ml
1621.9
1925.0
1.05
25
248
(37021550) Renin [Units/volume] in Plasma --upright
32
304
1.05
0.07
1.1
1.3
mu/l
103.6
77.7
0.18
23
214
(3034426) Prothrombin time (PT)
41
393
1.04
0.06
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
126
1286
0.98
0.06
1.1
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
94
0.85
0.06
1.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
184
1869
0.98
0.06
1.8
1.9
ug/l
20.1
22.6
0.65
177
1814
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
82
841
0.97
0.06
1.7
1.5
g/l
0.9
0.9
1.24
82
835
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
58
562
1.03
0.06
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
171
1683
1.02
0.06
1.3
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
25
264
0.95
0.06
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
131
1286
1.02
0.06
1.1
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
58
563
1.03
0.05
1.7
1.6
ug/l
6.5
5.0
0.20
46
406
(1002224) Polysomnography panel
414
4175
0.99
0.05
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
35
336
1.04
0.05
1.0
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
12
110
1.09
0.05
1.3
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
366
3691
0.99
0.05
2.6
2.4
g/l
3.6
3.6
0.10
352
3495
(40768804) Tissue Pathology biopsy report
5561
55692
1.00
0.04
2.2
2.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
345
3478
0.99
0.04
3.1
3.2
nmol/l
0.8
0.8
0.31
270
2692
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
167
1691
0.99
0.04
1.2
1.2
u/ml
3.9
4.1
0.10
75
745
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
15
140
1.07
0.04
1.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
928
9239
1.00
0.04
2.9
3.1
e9/l
4.1
4.1
0.10
706
6782
(40757373) Influenza virus identified in Isolate
30
312
0.96
0.04
1.4
1.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
198
1959
1.01
0.04
5.8
6.5
mg/l
12.4
12.1
0.53
185
1767
(3015183) Erythrocyte sedimentation rate
47
457
1.03
0.04
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
496
4989
0.99
0.04
3.2
3.0
g/l
0.5
0.3
2.08
231
1957
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
109
1106
0.99
0.03
1.3
1.2
u/ml
19.8
42.4
1.20
11
87
(3041354) Potassium [Moles/volume] in Venous blood
205
2031
1.01
0.03
2.6
2.4
mmol/l
4.1
4.1
0.66
205
2014
(3035285) Chloride [Moles/volume] in Venous blood
205
2031
1.01
0.03
2.6
2.4
mmol/l
105.3
105.5
0.33
205
2014
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
110
1115
0.99
0.03
1.3
1.3
u/l
16.3
12.8
0.40
97
1017
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
77
757
1.02
0.03
1.1
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
357
3591
0.99
0.03
1.5
1.6
e6/l
9782.0
15059.1
3.16
271
2556
(4268621)
115
1136
1.01
0.03
2.4
2.2
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
11
102
1.08
0.03
3.0
1.6
%
20.6
18.1
—
5
51
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
21
201
1.04
0.03
1.5
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
100
1013
0.99
0.03
1.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
11
118
0.93
0.02
1.9
2.5
—
—
—
0
0
(3001729) Color of Synovial fluid
12
128
0.94
0.02
1.2
1.7
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
148
0.95
0.02
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
751
7532
1.00
0.02
3.8
3.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
118
1168
1.01
0.02
4.3
4.9
u/ml
163.4
116.4
0.16
22
345
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
88
869
1.01
0.02
1.0
1.0
u/ml
0.1
0.6
1.32
17
201
(3020491) Glucose [Moles/volume] in Blood
93
941
0.99
0.02
1.4
2.0
mmol/l
7.2
7.0
0.20
58
649
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
109
1101
0.99
0.02
1.3
1.2
u/ml
79.4
82.0
0.04
11
49
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
596
5978
1.00
0.02
2.2
2.3
g/l
3.9
3.8
0.40
364
4233
(4133840)
29
298
0.97
0.02
1.3
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
19
183
1.04
0.01
1.1
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
598
5989
1.00
0.01
2.2
2.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
34
334
1.02
0.00
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
34
334
1.02
0.00
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
34
334
1.02
0.00
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
34
334
1.02
0.00
1.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
42
414
1.01
0.00
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
129
1284
1.00
0.00
1.1
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
210
2106
1.00
0.00
1.4
1.5
g/l
29.8
32.4
2.02
191
1883
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
166
1654
1.00
0.00
1.2
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
599
5996
1.00
0.00
2.2
2.3
g/l
7.5
7.5
0.10
380
4412
(3014891) Appearance of Pleural fluid
21
214
0.98
0.00
1.8
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
25
246
1.02
0.00
1.1
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
15
152
0.99
0.00
2.1
1.7
umol/l
47.2
46.7
0.01
15
152
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
13
129
1.01
0.00
2.2
2.2
mmol/l
0.3
1.1
—
7
84
(3041806) Other cells [#/volume] in Blood by Manual count
11
111
0.99
0.00
1.4
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
46
458
1.00
0.00
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
18
180
1.00
0.00
1.2
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
11
115
0.96
0.00
1.1
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
64
640
1.00
0.00
1.4
1.3
pmol/l
74.7
108.6
0.31
19
201
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
92
921
1.00
0.00
1.0
1.1
mg/l
295.6
291.1
0.27
84
826
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
72
721
1.00
0.00
1.4
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
72
721
1.00
0.00
1.4
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
14
138
1.01
0.00
1.2
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
13
134
0.97
0.00
1.2
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
14
135
1.04
0.00
1.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
17
167
1.02
0.00
1.5
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
19
188
1.01
0.00
1.1
1.1
—
—
—
0
0
(3036489) Thrombin time
478
4780
1.00
0.00
2.1
1.9
s
22.2
21.7
0.56
415
4235
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
13
128
1.02
0.00
2.7
1.7
%
68.6
59.9
—
8
77
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
16
161
0.99
0.00
1.2
1.2
ug/l
73.2
115.8
—
10
103
(3023487) Leukocytes [#/volume] in Peritoneal fluid
52
518
1.00
0.00
2.4
2.0
e6/l
8824.1
2843.2
0.33
42
348
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
30
300
1.00
0.00
1.0
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
114
1136
1.00
0.00
1.3
1.2
u/ml
60.1
50.9
—
5
55
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
26
264
0.98
0.00
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
68
676
1.01
0.00
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
32
321
1.00
0.00
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
10
98
1.02
0.00
2.9
2.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
12
122
0.98
0.00
1.3
1.1
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
5
53
0.94
0.00
1.0
1.0
—
22.5
—
0
14
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
9
94
0.96
0.00
1.2
1.1
—
—
—
0
0
(3035153) Lemon IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3042628) Porphyrins [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
36.0
—
0
8
(3008343) Lysozyme [Mass/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
0.4
—
0
7
(3040794) Aluminum [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3019529) Immunofixation for Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033463) Neutrophils [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014178) Parietal cell Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002853) Influenza virus B Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
5
53
0.94
0.00
1.0
1.0
—
27.0
—
0
8
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
62
0.97
0.00
1.8
1.3
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H7_GLAUCSUSP and mortality.

Females

Parameter HR [95% CI] p-value
H7_GLAUCSUSP 0.885 [0.81, 0.96] 0.004
Birth year 0.993 [0.98, 1.0] 0.071

During the follow-up period (1.1.1998 — 31.12.2019), 9216 out of 55203 females with H7_GLAUCSUSP died.

Males

Parameter HR [95% CI] p-value
H7_GLAUCSUSP 0.912 [0.83, 1.0] 0.058
Birth year 0.987 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 6277 out of 32273 males with H7_GLAUCSUSP died.

Mortality risk

Mortality risk for people of age

years, who have H7_GLAUCSUSP.

N-year risk Females Males
1 0.079% 0.157%
5 0.477% 1.024%
10 1.123% 2.475%
15 2.312% 4.865%
20 3.797% 8.204%

Relationships between endpoints

↥

Index endpoint: H7_GLAUCSUSP – Glaucoma suspect

GWS hits: 44

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data